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 ABSTRACT 
 
 This work describes the ongoing analysis of blood noninvasively in vivo along 
with the in vitro validation of the algorithm. The blood is taken as two components, red 
blood cells and plasma, both of which cause elastic emission (from Mie and Rayleigh 
scattering) and inelastic emission (from fluorescence and Raman emission). The 
algorithm describes the linear dependence of the volume fractions of both red blood cells 
and plasma with both the elastic and inelastic emissions where the two equations are 
independent. These equations are used to calculate the Hematocrit which is defined as the 
volume fraction of red blood cells in the total volume of blood. We believe that 
monitoring changes in the Hematocrit with sufficient sensitivity could give information 
about many physiological parameters including an early indication for internal 
hemorrhaging. The stability of the baseline was analyzed in 10 test subjects across 29 
experiments including over 8 million frames of data to give the smallest physiological 
increment of ±0.033 Hematocrit units. Compared to the medical standard blood draw 
method, with a standard deviation of ±2.0 Hematocrit units, our device is 60 times more 
sensitive to changes in the Hematocrit. Repeating patterns in the Hematocrit can be 
analyzed by a Fourier transform to give respiration rate and pulse rate earning the title of 
“big data.” Changes in the Hematocrit were also observed in dialysis patients (where the 
blood is manually cleaned due to kidney failure) and in a rat model where large portions 
of the blood can be removed and reintroduced. Blood loss and addition of fluid reveal 
changes in the Hematocrit that are distinguishable from the baseline. The algorithm was 
validated by a well-defined in vitro system modeling the blood components. The model 
 demonstrates that an optically thin sample in the linear range produces a good fit by the 
algorithm. Finally, the blood was analyzed in vitro to demonstrate that the red blood cells 
and plasma show linearity within the physiological ranges observed in vivo. At 830 nm 
excitation, the same wavelength used in vivo, volume fractions of red blood cells and 
plasma at the physiological range demonstrate linearity. All of the experiments and 
analysis appear to give evidence supporting the measuring of changes in the Hematocrit 
noninvasively in vivo on a medically useful timescale.    
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 1. Introduction 
 
1.1.   Previous Work and Motivation for Noninvasive in vivo Blood Analysis 
 The Chaiken lab began investigating in vivo measurements of blood in 1997 with 
the motivation to achieve noninvasive blood glucose. Published results in 20001 made 
claim to be the first published noninvasive in vivo Raman measurement of blood glucose 
followed by a succession of subsequent articles 2001.2,3,4 This measurement of blood 
glucose was (and still is) somewhat of a “holy grail” due to implications for replacing the 
US Food and Drug Administration (FDA) approved finger stick method. Diabetes was a 
growing issue in 2000 and still is with over 29 million in the US, or about 9.3 % of the 
US population affected in 2014.5 While prevention of diabetes is a huge priority, it is also 
important to care for those living with the disease. Individuals with type 2 are able to 
control symptoms if they know their blood glucose levels but daily pricking of fingers is 
not appealing. In order to achieve success, the new method of measurement must be 
superior to the FDA-approved finger stick. 
 The original Chaiken Group noninvasive prototypes required a test subject to hold 
a finger against an aperture/orifice on the Tissue Modulator to analyze the volar side of 
the fingertip, as depicted in Figure 1.1.1 The volar side of the finger was chosen due to 
the network of blood vessels beneath the skin with a relatively high perfusion close to the 
surface. The aperture was aligned with the focus of the laser and the light collection 
system to ensure collection of signal from blood vessels. In some prototypes, the test 
subjects could align their fingers using three small bumps the size of Braille dots for 
positional reference. 
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Figure 1.1. Schematic diagram of the early prototype Tissue Modulator used to obtain 
glucose measurements.1 
 
 In 20056 the Chaiken lab published another small clinical study showing 
noninvasive blood glucose results compared to the FDA-approved HemoCue.7,8,9 While 
the data showed glucose levels could be measured with accuracy and precision 
commensurate with the HemoCue at low glucose levels (e.g. <129 mg/dl) paradoxically it 
was not adequate at higher glucose levels. This study provided optimism for eventually 
producing accuracy and precision with a noninvasive in vivo measurement of blood 
glucose; however, there remained issues preventing further accuracy. Two of the more 
pressing issues were 1) the then current enabling technologies and 2) the existing 
understanding of physiological effects on in vivo measurements. 
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 The onset of the project in 1997 followed a time of improvement of the enabling 
technologies for Raman spectroscopy.10,11 At the time, advancements made these types of 
experiments possible whereas they were impractical before. With the pace of 
technological advancement, there are now enabling technologies far surpassing those at 
the start of the project.12,13 Specifically, significant advances have been made in lasers, 
filters and detectors. Continuous wave lasers in the physiological window are smaller, 
more efficient, and easier to couple to measurements either by free space or fiber. Pulsed 
lasers with higher peak power and sufficiently high repetition rates are now available that 
will allow temporal filtering to produce much higher signal to noise ratios than before. 
The increasingly advanced technology is paving the way for noninvasive in vivo blood 
glucose monitoring in the near future. 
 One of the most difficult factors to account for with in vivo measurements can be 
generalized as “human factors” (HF’s) and issues relating to physiological factors. HF’s 
encompasses many different factors that we understand and some yet to be uncovered. 
One human factor involves the “human-machine interface” and it relates to the 
positioning of the laser on the skin, the pressure of the finger against the aperture needed 
to ensure stable physical placement, and the effect of that pressure on the perfusion and 
composition of blood in the region probed by the laser light. Figure 1.2 shows a finger 
pressed against the position-detection pressure monitor (PDPM)14,15 which monitored the 
positioning and pressure of a finger in the instrument in laser prototypes. A person simply 
cannot sit motionless on an arbitrary spatial or temporal scale, regardless of motivation, 
necessitating the PDPM to account for movement and pressure during the measurement 
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process in order to facilitate, inter alia, automatic selection of the most reliable data for 
processing to a glucose measurement. 
 
Figure 1.2. The PDPM system measures both the position and contact area of the 
fingertip along with the applied pressure.14 
 
 The effect of positional variation on the information content of skin spectra also 
arises from near infrared (NIR) fluorescence in both static tissue and blood. Investigation 
has demonstrated that at incident powers allowed by the IRB, the fluorescence from skin 
is initially not constant over the first several minutes indicating that something is 
happening to the fluorophores in the irradiated volume on the molecular level.16,17 Not all 
contributing molecules to this signal are known but several major contributors have been 
documented.17 The fluorescence signal is degraded by the NIR source and will decrease 
for about the first five minutes, which we call “photobleaching.” It was also demonstrated 
that the rate of decay is commensurate with the laser power.  
With flowing blood, there is constantly new unbleached blood passing through the 
focus. However, we observe that once a spot is bleached the fluorescence becomes 
consistent, demonstrating the majority of bleaching to be from the static tissue. When the 
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focus of the laser moves across the finger, there is a new period of bleaching for the 
unbleached area. We have established by direct observation that once a spot has been 
bleached, it remains bleached for at least 45 minutes then eventually fades with all 
contrast gone 24 hours later.  
Pressure of the finger against the aperture is an issue for both too much pressure 
and not enough pressure. Calibration of glucose concentration depended on 
measurements of a finger both pressed and unpressed where the unpressed had a normal 
blood flow and pressing a finger would evacuate blood from the region providing a 
“blank.” It was hypothesized in the small clinical trial that most of the outlying data 
points corresponded to either insufficient or excess pressure. These types of human 
factors are intrinsic to in vivo measurements and must be accounted for if well-defined 
measurement processes and machine executable algorithms are to be designed. 
The other challenge to obtaining acceptable noninvasive glucose measurements 
involves achieving a better understanding of physiological effects on in vivo 
measurements in at least two ways. First, the tissue modulation algorithm involves 
moving blood, in particular red blood cells (RBC’s) during a measurement cycle that 
causes the cloudiness, i.e. the turbidity of the probed volume to change. An improved 
treatment of the effect of light propagation in turbid media on making quantitative 
measurements is required and will be described in this thesis. Also, the movement of 
glucose between the intravascular space and the interstitial volume complicates 
measurements in a completely different manner but that will not be within the scope of 
this thesis.  
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To perform quantitative spectroscopic measurements in turbid media, using a 
completely new algorithm that could also be used in glucose monitoring, in 200918 
Chaiken and Goodisman published a new algorithm for monitoring Hematocrit (Hct). Hct 
is defined as the volume fraction of RBC’s expressed as a percentage of the total blood 
volume that includes only RBC’s and plasma. The Hct and plasma volume are calculated 
by simultaneous measurement of both elastic emission (EE), which includes all Rayleigh 
and Mie scattering, and inelastic emission (IE), a combination of both fluorescence and 
Raman scattering. The plasma volume obtained using this algorithm is corrected for the 
turbidity caused mostly by the RBC’s and so when combined with a glucose signal from 
plasma constitutes an improvement over our earlier approach for measuring glucose. 
But, in its own right, we note that the leading preventable cause of death, 
worldwide, civilian or military, for all people ages 18-45 is undetected internal 
hemorrhage for which Hct, if measurable with sufficient precision, accuracy and 
sensitivity, may be an early indicator.19,20,21 Thus, not only is the Hct measurement an 
important medical technology to be used for noninvasive glucose monitoring, but it could 
also be used clinically for the Hct and intravascular plasma volume measurements 
themselves. These are highly regulated quantities that could form the basis for at least 
one new vital sign and enable improved diagnosis and treatment of a variety of medical 
conditions.  
 
1.2.   History of Hematocrit Measurements 
 The term Hematocrit traces back to 1891 when German scientist S. G. Hedin used 
a hand-crank device to spin blood and thereby pack RBC’s into the bottom of a tube.22,23 
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Variations of this method are being used today with a centrifuge, but the concept remains 
the same where the Hematocrit is determined as the height of the RBC’s in the tube 
divided by the total height of the blood. Hct measurement can be used as a vital sign 
where deviations from normal can indicate health issues. The normal ranges of Hct or 
packed cell volume (PCV) fraction depend on the size of the blood vessel from which the 
blood in question was sampled. In large vessels the Hct is 0.40-0.53 for a Caucasian man 
and 0.36-0.48 for a Caucasian woman.24 On the other hand, smaller vessels such as the 
capillaries are thought to contain blood with an Hct of around 0.15 although accurate 
measurement of Hct in the capillaries remains elusive because a finger stick will puncture 
larger vessels beneath the capillaries.  
Photoplethysmography25 involves the use of light absorption to monitor the 
presence of blood in a volume of tissue. In 1970 Victor Twersky described a theory for 
optical absorption measurements in a solution composed of scattering particles suspended 
in an absorbing medium that was applied to measurements of whole blood and cell 
cultures.26 The turbidity correction proposed by Twersky is used in oximetry and 
hemoglobinometry both of which require two wavelengths, one being the isosbestic point 
for the oxy-deoxy hemoglobin binary equilibrium at 805 nm and other wavelengths.27 
Hemoglobinometry requires that a second wavelength be employed that is both sensitive 
and selective to water absorption in the intravascular space.  
Unfortunately the NIR water absorption spectrum is overlapped with broad 
protein, carbohydrate and lipid-based absorptions, and the absorption by interstitial water 
is not differentiated from intravascular water. Searching for wavelength combinations is 
hampered further by the need to overlap the two wavelengths in space because very 
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different scattering coefficients can result as the wavelength difference increases. Finally, 
the Twersky algorithm assumes a direct and constant relationship between the Hct and 
total hemoglobin concentration (Hgb) and it is not necessarily constant in time and it is 
certainly not constant across patients. 
 One of the underlying issues with older classical types of measurements is 
the need to remove blood for analysis. An instrument called the CRIT-LINE28 makes the 
claim of being a noninvasive Hematocrit measurement for dialysis patients, though that 
claim is somewhat misleading. The claim to be noninvasive holds true only if the patient 
is attached to a dialysis machine which is itself invasive. The CRIT-LINE attaches to the 
dialysis machine which is used to clean the blood for patients with renal failure 
demonstrated in Figure 1.3.27 Whole blood is analyzed before entering the dialysis 
machine through a transparent window of known dimensions and the Hct is calculated 
based on the Twersky algorithm. This in vitro measurement of blood avoids interferences 
from the static tissue and keeps the relationship between Hct and Hgb fairly constant over 
the measurement. While this method of Hct measurement is incredibly useful for dialysis, 
it is only useful in a system where the blood is removed. Chapter 2 will describe in more 
detail the measurement process and algorithm to obtain the Hct and the plasma volume 
(PV) simultaneously noninvasively in vivo.  
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Figure 1.3. Left: Fresenius (Gambro) dialysis machine, Right: In-line spectral cell 
showing probing light.  
 
1.3.   Scope and Layout for the Dissertation 
 When I joined the Chaiken lab at the end of 2012, Dr. Bin Deng was performing 
post-doctoral work on noninvasive in vivo plasma volume and Hematocrit (PVH) 
measurements without graduate student participation. At the time, Dr. Chaiken and Dr. 
Deng were set up for both animal studies on Sprague Dawley® rats and human studies on 
dialysis patients in collaboration with Dr. Sriram Narsipur of the Upstate Medical 
University. I was immediately introduced to all Hct projects while learning on the job. 
The dialysis study was nearly complete when I joined but I had significant input on the 
animal studies. Once Dr. Deng moved on, I took the lead on all Hct related projects along 
with my development of an in vitro project to validate the PVH algorithm used for Hct 
calculation. 
 In this thesis the instrument dedicated to in vivo analysis using the PVH algorithm 
for measured plasma volume and Hematocrit in both rat and human subjects using 
interchangeable probes will be referred to interchangeably as either the PVH or the 
LighTouch Medical (LTM) Instrument. The particular prototype currently in use in the 
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Chaiken Group also has the capacity to produce Raman spectra as well although it is 
clear that a stand-alone PVH device could be produced that would be very small, 
portable, battery powered and possibly even wearable.  
Unlike the old system where the finger was held against the aperture, the new 
system includes a finger probe connected by fiber optics much like the ubiquitous finger 
clip used in pulse oximetry. The existing framework obtained from the published glucose 
measurement research led to a quick transition toward clinical type studies for PVH. 
However, having the capacity to measure existing physiological parameters with 
radically improved accuracy, precision and sensitivity immediately revealed some gaps in 
our understanding of the same, necessitating more foundational types of studies. Since 
the amount and type of data produced by the PVH is unprecedented, being able to 
rationalize the observations in terms of known and relatively well understood or at least 
accepted facts and principles adds to our confidence that we are actually measuring what 
we think we are measuring.  
The constants in the PVH algorithm have been calculated several ways including 
the use of scattering and absorption coefficients but the latest calibration was obtained 
from a study on dialysis patients. Data collected at the dialysis center included nine 
patients over several months and was published27 with a comparison to the FDA-
approved CRIT-LINE measurements. This provided a calibration of the PVH based 
device that has been used ever since. The LighTouch device showed comparable Hct 
values with the added information of plasma volume while making a truly noninvasive 
measurement. While the measurements proved encouraging, a “motion defect” caused by 
a mismatch in fiber optics causes large shifts in the signal when the patient moves.  
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Experiments at the dialysis center were ideal because of large shifts in the Hct 
with a known cause in a human subject. The function of dialysis serves to clean blood of 
patients with renal failure. The blood is pumped out of the body and contacted to a 
dialyzing solution across a semipermeable membrane which allows flow of waste 
products out of the blood and into the dialyzing solution before being pumped back into 
the body. The dialyzing solution is a glucose solution that gives an added benefit for us to 
also observe changes in the glucose Raman features. The removal of fluid always causes 
the Hct to increase during the course of dialysis although the amount depends on the rate 
of fluid removal and the rate of “back-filling” of fluid from the interstitial space into the 
intravascular space. The background and theory along with the calculation of the 
algorithm are presented in Chapter 2.  
 One of the most foundational studies that can be done with a medical device is to 
define what constitutes a normal baseline. The investigation of a baseline has taken the 
shape of the subject sitting or lying still and being silent, e.g. not even speaking for up to 
two hours at a time. Observations can be made about the tendency for drift with a filling 
bladder or different fluctuations appearing due to changes in breathing patterns while 
sleeping. The LighTouch was calibrated using the FDA-approved CRIT-LINE and it is 
interesting to combine LighTouch measurements with established physiological 
parameters (e.g. volume and mass of urine if subject urinates immediately before and 
after baseline measurement to search for internal consistency). All of these types of 
observations are essential to establish normal behavior as precisely as possible and 
thereby to prevent false diagnoses and to enable more effective treatment using the 
device.  
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With a probe attached to the finger, a person has the capacity for movement and 
that movement can cause shifts in the Hct due to “orthostatic redistribution” of blood. For 
instance, when a person moves in a way that flexes the abdominal muscles, as in the well-
known Valsalva maneuver (VM)29,30, the venous return via femoral vein to the heart is 
impeded because the diaphragm muscles expand. This restricts the movement of RBC’s 
differently than the plasma motion showing a temporary decrease in Hct near the time 
and place of the contraction, which is before the blood enters the heart. How this scenario 
plays out in the subsequent cardiac output is mostly known in terms of heart rate and 
blood pressure, as this is a well-defined medical protocol that is used in assessment of 
cardiac performance. The PVH also measures pulse rate as well as Hct and plasma 
volume in real time. A portion of the work presented here documents and attempts to 
rationalize the response of the PVH to such physiological stimuli as further validation of 
the algorithm. 
 As internal stimuli can cause fluctuations, so can external stimuli. The importance 
of an applied pressure at the measurement site was addressed with the PDPM on the old 
system but the new system employs Velcro to attach the probe to the finger at constant 
pressure. A final product is more likely to have a clip for the finger, also at constant 
pressure, but the prototype can show results indicating when the pressure is not optimal. 
If the measurements themselves can be interpreted to indicate when the probe pressure is 
not appropriate then systems can be designed to automatically correct measurements 
under such conditions. Chapter 3 will investigate what constitutes “normal” and induce 
both internal and external stimuli to observe changes. A portion of this chapter is 
reproduced from work that was published.31 
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 In conjunction with the dialysis studies from Chapter 2, a rat model was also 
investigated. The palm of a rat paw shows similarities to the human finger (e.g. ridged 
skin which led to a probe specifically designed for use in rat studies). A portion of the rat 
studies corresponding to Hct changes from fluid removal and replacement experiments 
was published32 in concurrence with the dialysis study. The use of a rat model allows for 
experiments that remove relatively large portions of blood followed by fluid 
replacements that would not be as viable an option in early human studies. These studies 
are essential to show the changing Hct as an indication to blood loss from the system. 
The data and analysis for rat studies are presented in Chapter 4, which has been partially 
reproduced from the published work.32 
 While the algorithm used for both the rat and human studies appears to behave as 
anticipated, it is also important to verify by an in vitro model the validity of the 
algorithm. Furthermore the algorithm provides a solution to a common and general 
problem, spectroscopic monitoring of solute concentration in slight but variably turbid 
solutions. A model system was designed in a cuvette containing quartz spheres as a 
scattering particle commensurate with the size of a red blood cell and solubilized 
porphyrin to model the fluorescence of the plasma. Due to the high density of quartz 
spheres, the background solution was a cesium chloride (CsCl) solution adjusted to a 
density of 1.42 g/mL after filtration, which kept the quartz suspended sufficiently long 
for a homogeneous measurement. The small but measurable background fluorescence 
from the CsCl modeled the constant background from the static tissue.  
A two dimensional calibration curve or “training set” was comprised of six 
concentrations of both quartz and porphyrin with all combinations for 36 samples. 
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Having two changing concentrations and two measured values, EE and IE, made for a 
simple bilinear fit contingent on concentrations comprising a linear range in both 
measured values. This algorithm for blood analysis takes the same form where, by pure 
good fortune, the RBC’s and plasma happen to be linearly correlated to EE and IE at the 
normal concentrations observed in the fingertips.  
This model system established well-defined linear relationships for analyzing 
samples within the concentration ranges. The algorithm was utilized in modeling the 
settling of the quartz spheres over time, which was similar in shape to sedimentation 
curves. Experimental analysis of the settling was fit using computational modeling giving 
credence to the algorithm. The utility of a model system is to control or measure as many 
factors as possible for the testing of the algorithm since that gives confidence to the 
ability of the algorithm to perform in the noninvasive in vivo setting, in which the 
characteristics of the living medium cannot be manipulated with complete impunity. This 
work was published33 and is reproduced in Chapter 5. 
After modeling the algorithm in a well-defined system, we ventured into 
analyzing the blood in vitro. Initially the blood came from rat study experiments to 
maximize results obtained from procedures performed on the rats. The blood collected 
would be centrifuged and separated by pulling out the pure plasma then washing the 
RBC’s with phosphate buffered saline (PBS). The studies started on the same instrument 
as the quartz and porphyrin in vitro system at 785 nm but the scattering and fluorescent 
signal from the RBC’s dominated the signal at that wavelength. Linear ranges were 
established independently for both plasma and RBC’s and both were well behaved 
separately. When the algorithm was applied to a training set, similar to the model system 
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from Chapter 5, there was a good fit of the data with slopes near 1 and intercepts near 
zero.   
Overall, blood is a difficult solution to handle in vitro. The RBC’s are somewhat 
delicate such that an abrasive handling can cause them to burst, which makes 
homogenizing a solution difficult. The RBC’s also tend to cluster together or stick to the 
walls of the container, which affects the scattering of the light and observed 
concentration. The samples were diluted into a linear range but difficulties persisted. At 
785 nm excitation the scattering from the RBC’s dominates over the plasma making the 
sampling difficulties stand out. Also, the linear range for RBC’s at 785 nm was slightly 
below the normal physiological range (0.003-0.005 v/v) due to the greater scattering 
coefficient. Therefore, it was determined that a different wavelength, 830 nm which is 
used in vivo, may give a better balance between signals from RBC’s and plasma and be 
more directly comparable to the in vivo measurements.  
The studies on the 785 nm system deliver the laser to the top of the cuvette 
through a hole in a mirror and collects the backscattered light from the mirror. The same 
orientation was used for the 830 nm system in the previous experiments so that only the 
wavelength was changed. Experiments on each component of the blood separately to find 
linear ranges revealed that both the RBC’s and plasma were linear above the normal 
physiological range in both EE and IE. However, when mixed for a training set the IE 
was not as stable for sufficient linearity as opposed to the EE which was sufficiently 
linear. We hypothesize that a larger volume fraction of RBC’s compared to the 785 nm 
study may be causing multiply scattered photons from the side walls of the cuvette to 
cause variability in the fluorescence.  
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Having multiple probes for the 830 nm system allowed for the arrangement where 
the laser was delivered through the top of the cuvette and the signal was collected 
through the side of the cuvette at a 90 degree angle. The probes were aligned such that 
the focus of each probe was overlapping in space. In this orientation both the EE and IE 
decreased as either plasma or RBC’s were added to the solution giving evidence that the 
turbidity significantly decreased the amount of light reaching the focus of the light 
collection system. The path length through the blood solution in the cuvette is long (~1 
cm) compared to the diameter of the capillaries (~10 µm), a factor of 100, making this in 
vitro approach much more susceptible to multiple scattering effects. Despite the greater 
path length through the RBC’s in vitro there is still linearity in volume fractions greater 
than the physiological ranges observed by the in vivo measurements.  
The in vitro blood trials showed that linear relationships exist for both RBC’s and 
plasma at volume fractions relevant to in vivo measurements considering changes in path 
length. However, blood turns out to be difficult to homogenize and keep consistent 
throughout in vitro experiments. Although attempts to replicate the in vitro model 
experiments employing the components of whole blood was unsuccessful at 830 nm, the 
individual components demonstrated linearity at physiologically relevant volume 
fractions which fulfils the basic requirement for the algorithm to be applicable to that 
system. Experiments comprised of in vitro blood are described in Chapter 6. 
Combining results from both in vivo and in vitro experiments facilitates a broader 
understanding of the data collected. Experiments in vivo characterized “normal” 
Hematocrit changes in human patients along with known changing Hct in the dialysis 
center. A rat model verified results obtained from the dialysis studies and provided a 
17 
 
 
broader range of possible experiments. Modeling the algorithm with a well-defined 
system provides confidence in the ability of the algorithm to measure small changes and 
in vitro blood experiments show signal linearity in relevant volume fraction ranges.  
 
1.4.   Hypotheses Investigated 
i) Hematocrit acts as a vital sign with only relatively small measurable changes 
over time due to physiological effects. The Hct monitoring can also be used to 
measure other vital signs such as the pulse rate and breathing rate for comparison. 
 
ii) Changes in Hct due to loss of blood are measurable and significantly different 
from normal physiological changes.  
 
iii) The PVH algorithm, used to calculate the Hematocrit in vivo, applied to a 
model system in vitro demonstrates the ability to accurately calculate changing 
concentrations of a two-phase optically thin system.   
 
iv) Physiologically relevant volume fractions of blood components show linearity 
with respect to both EE and IE.   
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2. Background and Theory 
 
2.1.   Measuring EE and IE in vivo 
 For the purpose of presenting the PVH algorithm, we take the skin as 
being composed of three phases15,18,21,34, static tissue that deforms when mechanical 
stress is applied, and blood that is itself composed of 2 phases: red blood cells and plasma 
that both move when mechanical stress is applied. The distribution of scattering centers 
and fluorophores is considered spatially homogeneous, the specific nature of the cells 
comprising the static tissue is considered irrelevant, and the scattering contribution of the 
RBCs is dominant. There is a region beginning from the outermost skin surface, called 
the stratum corneum and extending to beneath the surface a certain depth where there is 
capillary blood, interstitial fluid and tissues that are viable, shown in Figure 2.1. Incident 
NIR light that penetrates to just below the specific depth where the tissues begin to have 
capillaries and are viable makes only a small relative contribution to the net amount of 
light remitted from the exact same surface location as the incident light. Therefore the 
remitted light has sampled dead tissues on the surface and viable tissues containing only 
capillaries working with human volar side fingertip ridged skin and NIR incident laser 
light at, for example, 830 nm. Given the scattering and absorption coefficients from 
published values35,36 measured in vitro shown in Table 2.1, the propagation of remitted 
light generated as described occurs in the single scattering limit. 
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Figure 2.1. Schematic of laser penetration during in vivo blood measurements showing 
the majority of collected photons as singly-scattered. 
 
Table 2.1. Absorption and scattering coefficients for the three phases comprising skin 
from in vitro measurements. 
phase absorption coefficient (cm-1) scattering coefficient (cm-1) 
r=RBC 4.5 300 
p=plasma 0.3 0.6 
t=static tissue 5 12 
 
Since the volume percent occupied by blood37 in relatively well perfused fingertip 
skin i.e.3-5% of the total is still quite small, the skin in that region should be considered 
optically thin (i.e. the average photon passes through the medium without an absorption 
or scattering event) despite the presence of the strongly scattering RBC’s. Note that the 
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Hct of capillary blood38 is much smaller than in blood sampled from any larger vessels, 
for example 10%-30% is a realistic full range for capillary blood. It is easy to estimate a 
volume percent or concentration range over which the production of fluorescence is 
linear in fluorophore concentration. The production of fluorescence has long been known 
to be linear in concentration in optically thin materials39 and we expect the production of 
Raman scattered light to be the same in that respect.  
When one actually probes fingertip skin14 with NIR laser light a typical spectrum 
of the remitted light is given in Figure 2.2. There is always light of the same wavelength 
as the incident light and light shifted to longer wavelengths. We refer to the unshifted 
light as being elastic emission (EE) and the wavelength shifted light as being inelastic 
emission (IE). We note that there is obviously Raman scattered light in addition to 
fluorescence but we shall use the entire IE as indicated in Figure 2.2 without trying to 
resolve them. 
 
Figure 2.2. Intensity versus frequency from a typical 20 ms frame of Andor charge 
coupled device (CCD). The sections used to calculate the IE (500-1750 cm-1) and the EE 
(-30 to +10 cm-1) are shown.  The low shift integration limit for the IE is chosen to ensure 
that no EE is included in the IE. 
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First we note that a number of arbitrary baseline correction algorithms exist in the 
biomedical Raman literature40,41 but there really is no actual knowledge about how to 
separate the Raman from the fluorescence. A recent advance in baseline subtraction of 
the fluorescence from biological samples works based on Kasha’s rule42, stating that 
fluorescence emission is essentially constant for small changes in excitation wavelength 
while the Raman signal changes according to the excitation wavelength.43 After some 
processing of the signals, this gives a difference spectrum which essentially removes the 
fluorescence background. For purposes of applying the PVH algorithm, we assume that 
the EE and IE can be used exactly as shown in Figure 2.2 and note that for all practical 
purposes, e.g. stand-alone PVH devices, obtaining the EE and IE as shown could be 
easily accomplished with one wavelength, filters and single channel detectors, forgoing 
any need for CCD cameras and spectrographs.  
At any given Raman shift there is fluorescence and Raman emission 
representative of the constituents present in the probed volume of tissue. Direct 
observation of Figure 2.2 shows that Raman scattered emission is a small contribution to 
the total IE. Nevertheless, to the extent either the fluorescence or Raman changes in the 
course of time, the algorithm will produce an “apparent plasma volume change” or 
“apparent Hct change”. The photobleaching of the tissue autofluorescence by the probing 
laser itself causes changes in the apparent Hct and plasma volume whether the EE 
changes or not. Implicitly corrected for the turbidity, the apparent Hct and plasma volume 
represents a very sensitive and quantitative probe of chemical changes in the probed 
volume. 
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There is actually significant latitude in what raw measurement can serve as IE for 
this algorithm. In vitro validation of this algorithm with, for example, quartz spheres 
suspended in a fluorescent or Raman active fluid show that simple fluorescence or even a 
Raman signal corresponding to a single constituent can be used as the IE so long as the 
other assumptions in the model are satisfied. Using the IE as a measure of the overall 
chemical composition of a probed tissue volume is reasonable as long as the physical 
processes that generate the IE are mathematically independent of the processes that 
determine the strength of the EE. This ensures that the equations below can be inverted 
and we show specific data concerning the effect of photobleaching below. 
The EE is determined completely by the absorption loss experienced by the 
incident light and the physical scattering characteristics of the materials in the probed 
volume. The absorption loss is disconnected from the IE because the fluorescence 
quantum yield is independent of the absorption and scattering coefficients. Thus the EE is 
much more connected with all the physical processes that determine where and how light 
propagates in the tissues but less with how IE is produced.  
 
2.2.   Theoretical Model and PVH Algorithm 
In order to model the propagation of light in the probed volume using the 
radiation transfer equation34,44 (RTE) in the single scattering limit, we assume that the 
tissues are spatially homogeneous and that there are no voids. Moreover, when we apply 
external mechanical pressure to the tissue, or if the heart beats, sending a pressure wave 
throughout the intravascular volume, the blood moves but no voids are developed. These 
23 
 
 
assumptions can be summarized by the following equations as well as the definition of 
Hct. 
1 = 𝜙𝑟 + 𝜙𝑝 + 𝜙𝑠  (no voids)  [2.1] 
0 = 𝑑𝜙𝑟 + 𝑑𝜙𝑝 + 𝑑𝜙𝑠 (zero sum game) [2.2]  
𝐻𝑐𝑡 =
𝜙𝑟
(𝜙𝑟 + 𝜙𝑝)
⁄   (definition)  [2.3] 
where, ϕr, ϕp and ϕs denote the volume fractions of RBC’s, plasma and static tissue 
respectively. We previously published comparisons using this model to spatial scans of 
skin34 easily reproducing the measurements and suggesting that the model would also be 
accurate if we modeled temporal changes at one location over time (e.g. cardiac pulse, 
external mechanical pressure or Valsalva maneuver). Using the RTE in the single 
scattering limit, and as is known to be true for quantitative fluorescence measurements39 
in optically thin samples, the EE and IE are given by the bilinear forms. 
𝐸𝐸 = 𝜗1 + 𝜗2𝜙𝑝 + 𝜗3𝜙𝑟   [2.4] 
𝐼𝐸 = 𝜗4 + 𝜗5𝜙𝑝 + 𝜗6𝜙𝑟   [2.5]  
We thus have 2 independent equations in 2 unknowns and 2 quantities that we 
measure (e.g. EE and IE). If the equations are independent they can be inverted to allow 
calculation of the plasma volume fraction and the RBC volume fraction and by closure 
the Hct and the static tissue volume fraction.  
𝜙𝑟 = 𝑎 + 𝑏 (
𝐸𝐸
𝐸𝐸0
) + 𝑐 (
𝐼𝐸
𝐼𝐸0
)   [2.6] 
𝜙𝑝 = 𝑑 + 𝑒 (
𝐸𝐸
𝐸𝐸0
) + 𝑓 (
𝐼𝐸
𝐼𝐸0
)   [2.7] 
We have inverted equations 2.4 and 2.5 and expressed the result in the form of 
equations 2.6 and 2.7 because our immediate medical goal is best served with monitoring 
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changes in plasma volume and Hct since such changes are the indicators of deviations 
from homeostasis. Given the success of the CRIT-LINE, being able to monitor even 
relative changes noninvasively and in vivo for all patients is a worthwhile goal and 
possibly is less affected by calibration issues across individuals as would be the case for 
absolute Hct. 
With regard to absolute Hct, the quantities EE0 and IE0 are the average values of 
EE and IE and in practice these can be measured at the outset of a monitoring session, 
compared to the CRIT-LINE which calculates plasma volume from the initial Hct reading 
of a session, and then all subsequent changes are relative to the patient’s own previous 
state. They can also be a single set of values obtained by averaging the measured EE0 and 
IE0 values of a large number of people and this leads to calibration across individuals and 
possibly the capacity to monitor absolute Hct. Note that the parameters a-f contain 
absorption coefficients and quantum yields and if changes occur (e.g. oxygenation of the 
RBC’s) the background absorption and quantum yields for emission can be affected. In 
that case the PVH device will respond to changes in oxygenation of the RBC’s. 
Presently we are only concerned with relative changes and we have published25,45 
at least 3 different approaches to calibration: finding the appropriate values of the 
parameters a-f including from numerical modeling and the in vitro measured absorption 
and scattering coefficients of plasma, RBC’s and skin tissue. Minimally since we have 6 
parameters (e.g. a-f), we need a set of six pairs of EE and IE to pair with specific plasma 
volume and RBC volumes, in order to assign the values for parameters a-f. Note that 
using Equation 2.3 we calculate the individual plasma and RBC volumes from the Hct 
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and plasma volume given by the CRIT-LINE. Having more measured data pair sets can 
give more precise estimates of the optimal values for the parameters.  
 
2.3. Calibration of the algorithm 
 During a dialysis session monitored by the CRIT-LINE, there is real-time output 
showing the Hct with the associated Hgb, the oxygen saturation (SpO2), the relative 
accumulated %Δ of plasma volume since the beginning of the session and the elapsed 
time, shown in Figure 2.3. Digital output obtained from the CRIT-LINE produced a 20 
second time series for direct comparison. The PVH algorithm calculates the RBC volume 
and plasma volume separately to calculate the Hct as opposed to the CRIT-LINE which 
calculates the Hct directly under the assumption that the total volume of blood is constant 
in the probed volume (which is true for the in vitro cell). The CRIT-LINE uses another 
algorithm46 to calculate the accumulated change in plasma volume.  
 
Figure 2.3. Real time output of the CRIT-LINE.27 
 Dialysis sessions were conducted with simultaneous measurements by both the 
CRIT-LINE and the LighTough instrument. The CRIT-LINE produced data for both Hct 
and relative plasma volume averaged over 20 seconds while the LighTouch produced 
both EE and IE every 3 seconds. Data from both instruments were averaged over the 
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same timescale for comparison, shown in Figure 2.4. A bilinear regression for both the 
Hct and plasma volume on both EE and IE gave the parameters, a, b and c for Hct and d, 
e and f for the plasma volume.  These parameters a-f obtained from comparison to the 
CRIT-LINE were used for all subsequent studies for both human and animal subjects 
with consistent results.  
 
Figure 2.4. Training set used to obtain parameters a-f for use in all subsequent 
experiments including rats.27 
 
 The correlation between the Hct measured independently by the CRIT-LINE and 
the LighTouch instrument is quite good (r2=0.95, p<0.0001, N=18). Plasma volume is 
only indirectly calculated by the CRIT-LINE from the Hct as opposed to the LighTouch 
which calculates the plasma volume separately from the Hct. Despite there being nothing 
constraining the raw data to produce agreement in this new algorithm, there is 
nonetheless a correlation between the calculated Hct and plasma volume. To demonstrate 
the reproducibility between experiments, Figure 2.5 shows the Hct calculated by both the 
CRIT-LINE and LighTouch on a different patient obtained weeks later. Hct calculated by 
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the new algorithm used the a-f calculated from Figure 2.3 and the zeros, EE0 and IE0, 
obtained from the beginning of the experiment.  
  
Figure 2.5. 20 sec per data point from both the CRIT-LINE and the new algorithm.27 
  
 There are several factors at play but overall the general trend is conserved. First, 
the displacement of about 1-2 Hct units is due to the parameters a-f constraining the Hct 
to start at 28.35 for the LighTouch. Differences in skin tones between patients would 
present different levels of melanin and intrinsic NIR fluorescence which affects the IE.  
Presently we are more concerned with observing changes than calculating the absolute 
Hct though the present accuracy may be sufficient for many purposes. Second, the first 
≈600 seconds show a more rapid change in the Hct for the LighTouch than for the CRIT-
LINE. There is photobleaching of the autofluorescence in vivo that is avoided by the in 
vitro approach of the CRIT-LINE. To demonstrate that the data after the photobleaching 
tracks with the CRIT-LINE, the data is plotted differently in Figure 2.6. Separating the 
data into during and after photobleaching demonstrates a good linear correlation overall.  
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Figure 2.6. Same data from Figure 2.5 plotted to show correlation between two sets of 
measurements with a single set of “zeros” and a single set of a-f parameters previously 
obtained from a different patient.27 
  
 The black line from Figure 2.6 corresponds to the overall level of noise and 
sensitivity after the bleaching is completed. The trend and total change in Hct, after 
bleaching, between the CRIT-LINE and LighTouch tracked well in Figure 2.5 so an r2 of 
0.56 demonstrates variability from factors other than changes in the Hct. If the precision 
and accuracy of the CRIT-LINE are ignored, this data gives a signal to noise of about 1 
with an upper-bound of about 0.5 Hct units for the noise. This performance of the 
LighTouch out measures the conventional invasive Hct procedures47 and at least matches 
the performance of the FDA-approved CRIT-LINE. A single set of parameters obtained 
in this manner has been in use in the PVH for nearly 3 years. 
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3. Normal Physiological Responses 
 
3.1.   Importance and Motivation 
 The movement of water and water borne materials within and between the 
vascular system and other compartments within the body is a fundamental requirement 
for homeostasis45 requiring constant physiological regulation. The precise, real time 
continuous quantitation of these variables has proven difficult to achieve. Current 
technologies25 obtain signals from red blood cells and water that cannot be distinguished 
as intra or extra vascular fluid, and their movements and overall disposition follow the 
movement of the plasma, a variable essentially unobservable noninvasively until 
recently.15 The observation in real time of unusual compartment shifts, for example, 
could provide early indications of internal bleeding, simple dehydration, electrolyte 
imbalance, kidney failure, physical exhaustion, cardiac dysfunction and other serious 
acute and chronic conditions that allow medical professionals to provide timely 
interventions.20 In pediatric practice in which the sampling of fluids and tissues is 
particularly problematic, patients with chronic renal failure, cyanotic congenital heart 
disease and hematologic disorders would immediately benefit from our device. 
Undetected internal bleeding nearly always results in death that almost always can be 
successfully treated if the bleeding can be detected and located in time, or within the 
“Golden Hour”.19 
 Noninvasive hemoglobinometry, oximetry and Hematocrit measurement has its 
roots in the work of Victor Twersky26 who showed how to deal with the combined 
absorption and scattering of blood and other living tissues in closed form equations. The 
efficacy and validity of Twersky’s treatment is evident not only in the decades-long 
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utility of the pulse oximeter in medicine but also in the success of devices that analyze 
blood outside the human body.31,46 The use of hemoglobinometry to check for internal 
bleeding and other conditions is commonplace but there appears to be room for 
significant improvement48 with more than one factor contributing to this situation. 
 First, hemoglobin concentration (Hgb in grams/decileter) is more a measure of 
oxygen transport capacity and Hematocrit (Hct as a unitless fraction) is more a measure 
of blood viscosity. The same net Hgb could be consistent with larger or smaller RBC’s 
each with different hemoglobin content per RBC49. Thus the physiological implications 
of changes in either parameter may be subtly different. Second, in developing his 
algorithms Twersky assumed a constant relationship between Hct and Hgb 
(Hgb=35*Hct) and so the same data50,51 can be used to calculate either “Hgb” or “Hct” 
noninvasively with the result being that neither parameter is exactly what it is supposed 
to be.   
 But perhaps the most important shortcoming may be that while the raw data that 
goes into Twersky’s algorithm attempts to assess the presence of water (e.g. plasma in a 
manner that allows for quantitative comparison of hemoglobin content to water content), 
the absorption spectroscopy of intravascular water is indistinguishable with that of 
extravascular water. Thus the Twersky approach can be quite useful for some 
applications, such as spot-checking for anemia because the achievable absolute error for 
Hct or Hgb is roughly 8-9%. But it is less useful for dynamic physiological responses to 
perturbations that cause fast and large shifts in fluid content within and across 
compartments. The plasma increasingly maintains the intravascular pressure as the vessel 
size decreases and the motion of the plasma always precedes the motion of the formed 
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parts i.e. the RBC’s. RBC’s therefore do not track the movement of the plasma exactly 
and the presence of RBC’s does not guarantee the presence of intravascular water 
(plasma).  
 Absorption spectroscopy itself has shortcomings compared to other approaches 
for obtaining subsurface spectroscopic signals for use in noninvasive medical devices. By 
necessity, absorption spectroscopy involves measuring small changes on a large 
background of incident light and this entails a lower signal to noise than measuring 
fluorescence or even Raman scattered light, which are both background free 
measurements. It is an empirical fact that all biological tissues emit fluorescence when 
irradiated with NIR laser light and that this fluorescence bleaches (in other words 
decreases exponentially over time with continued irradiation). Furthermore Raman 
scattered light is superimposed on this “autofluorescence” and separating the two is at 
best problematic. At FDA allowed incident light power levels, spot sizes of ≈102 µm in 
diameter and any wavelength 785 nm or longer, bleaching of perfused skin is complete 
within ≈10 minutes and then is stable afterwards for an apparently indefinite time.  
 The source of the autofluorescence is at once from many sources and from no 
particular single source. Hemoglobin and other porphyrin containing materials are one 
obvious generic source but there are undoubtedly others and not being able to focus on a 
single source frustrates attempts to formulate countermeasures. Our particular interest in 
biomedical spectroscopy originated1 in trying to achieve noninvasive blood glucose 
monitoring by NIR Raman spectroscopy. We have long argued that the tissue modulated 
autofluorescence is a viable measure of blood volume in the probed volume of tissue. By 
“tissue modulated” we indicate that using various external perturbations (e.g. applied 
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pressure and temperature changes) to intentionally vary the perfusion and therefore 
fluorescence of the probed volume. Indeed, blood moves under the influence of external 
pressure but the surrounding “static” tissues simply deform. By subtraction we deduce a 
blood volume to associate with the Raman signals from specific analyte molecules to 
calculate their blood concentrations.  
 The issue of photobleaching is particularly important because if the amount of 
fluorescence per unit volume of blood is not constant then using emission to quantify 
blood volume will be dependent on the individual and may not stay constant for the same 
individual over time. Moreover quantitative monitoring (other than the rate of decay of 
the emission itself) is impossible during the bleaching period since the volumetric 
relationship is changing. However, experiments16 show that the residence time of blood 
in the probed and therefore bleached volume is small and so the volumetric relationship 
between emission and blood is always maintained, while that involving the static tissues 
surrounding the blood is not, until after the bleaching period. More importantly, we know 
that after the bleaching period, the fluorescence of plasma is a larger proportion of the 
total than before. Since the bleaching involves the static tissue, and the blood is 
constantly replenished, by emission spectroscopy the “water” in the tissue may be 
distinguishable from the “water” in the plasma, unlike in the use of absorption 
spectroscopy. If the blood were slowly bleached the long term baselines would all have a 
negative slope as more and more bleached blood would accumulate in the intravascular 
space, which is not observed, so we conclude that whatever bleaching occurs in the blood 
is much less than what occurs in the static tissue. 
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 Although the autofluorescence enjoys a good possibility for being a volume 
surrogate, the propagation of incident and generated light in the probed volume 
complicates scattering and it is not possible to “tissue modulate” a given volume of tissue 
without moving the RBC’s and altering the propagation of light into and out of the 
probed volume. By examination of the relative content of the gross phases present in 
tissue (for example the static tissue, RBC’s and plasma), and the elastic scattering 
coefficients of each, and then choosing excitation and remitted light collection geometry 
carefully, it is possible to ensure that the probed volume is effectively optically thin. In 
this case most if not all of the light collected is produced by single scattering interactions 
and this allows for a simple algorithm to simultaneously account for the mild but variable 
turbidity of the probed volume while quantifying the various kinds of emission. We have 
validated this approach in a model in vitro system33 in Chapter 7 below and termed the 
approach “binary spectronephelometry” (BSN).  
 Our previous experiments with dialysis patients demonstrated the need to 
understand baseline physiological regulation processes manifested by plasma volume and 
Hematocrit. A routine dialysis session typically requires 3-4 hours during which the 
patient must be stationary. Humans are not closed physical systems with heat and water 
being continuously lost to the surroundings so the stability of vital signs indicate that 
these processes are indeed occurring. Under dialysis the Hct increases steadily as 
indicated by the CRIT-LINE and we anticipate the same under normal conditions with 
healthy subjects. Insensible perspiration and normal kidney function continuously 
regulating blood composition causes the net intravascular water content of a test subject 
to decrease albeit at a much smaller rate than under dialysis. Experiments of fluid 
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removal and replacement in a rat model31 show consistent results but in this case the 
simultaneous variation of probe pressure and blood pressure due to anesthesia make such 
observations more difficult to quantify with our present ancillary instrumentation. Our 
earliest human experiments involved the Valsalva maneuver and tourniquets and also 
produced consistent, if small, effects. Therefore to show unequivocally that BSN directly 
monitors and successfully processes signals from plasma itself, we sought in this study to 
execute procedures that more clearly separate the movement of RBC’s from that of 
plasma.  
  
3.2.   Experimental 
 All procedures were conducted with local IRB (SUNY-Upstate Medical 
University) approval in Syracuse, NY (Appendix A). Photoplethysmography was 
performed using a Nellcore 200 commercial oximeter and sampling the test point 9 (TP9) 
or test point 10 (TP10) signals for the plethysmographic response at either 600 or 947 
nm.21 The Nellcore response was sampled using an ADInstruments Powerlab 2/20 and 
transferred from there to a PC. Note, the results rendered the greater the absorption the 
less the photocurrent. All other spectroscopic measurements employed a modified 
commercial Raman spectrometer (Lambda Solutions, Waltham, MA) and a specially 
designed probe intended to mimic the type of aperture-orifice shown in Figure 1.1. The 
probe has a rectangular, flat surface containing an aperture with a lens placed near the 
inside end of the aperture such that when the surface is pressed against the skin and held 
there using Velcro straps, the light is delivered to the skin extruding into the hole at 
approximately f=2.0. The delivery and collection is symmetric so the collection is also at 
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f=2.0 with an approximate 150 µm diameter spot size. The rest of the optics and filtering 
is standard for Lambda Solutions probes but there is an additional Raman notch filter 
(Semrock, Rochester, NY) placed between the collimating lens and the grating to allow 
adjustment of the EE and IE for optimum dynamic range.  
 The pictures in Figure 3.1 show how the probe is interfaced to the skin and the 
hand overall. Since Raman spectra are collected with the unit used in this study, a 
focused laser was employed but this may be unnecessary for PVH applications. The 
possibility of a stand-alone PVH-only probe could utilize a clip-type arrangement, as is 
standard for pulse oximetry which could be adapted for purposes of monitoring at various 
locations to localize suspected internal hemorrhage or for wearable applications. We have 
studied the effect of probe pressure on the results and it is important to not strap the probe 
too tightly as it can restrict blood flow, as will be seen below. In general, as long as the 
patient finds the probe comfortable and the aperture stationary relative to the skin surface, 
the pressure is adequate and valid, wherein interpretable results should be expected.  
                              
Figure 3.1. Two views of the finger probe used in this study. A disposable sheath could 
be used in addition to alcohol swabbing the probe between uses to insure cleanliness. 
  
Tissue is “soft matter” that extrudes into any hole that may constitute an optical 
aperture designed to produce reliable mechanical registration between the probe and the 
tissue to be probed. This leads to systematic short and longer time optical responses that 
will be discussed below. In addition, we can have blood pressure fluctuations for various 
reasons, as well as changes in oxygenation. The largest known source of error for this 
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probe is systematic. Whenever there is slight movement of the probe aperture with 
respect to the skin surface, the probing light reaches unbleached skin causing an apparent 
decrease in the Hematocrit, and then an increase as the skin bleaches17, typically reaching 
the same previously established equilibrium bleached level in less than 20 seconds, 
although more time is required if the amount of previously unbleached skin is 
commensurate with the original spot size (i.e. there was a large movement of the probe). 
 Test subjects included the PI, graduate and undergraduate students working in the 
lab. All test subjects understood the experimental procedures and consented to the 
experiments with the understanding that stopping at any point was acceptable. Data from 
students was used for their own purposes (e.g. undergraduate research final reports, 
Research Experience for Undergraduates (REU) posters and similar presentations) in 
addition to this thesis. Only results from the PI and myself were published in the open 
literature. Baseline data was collected while the subject lay still for an extended period of 
time, possibly sleeping. Fluid shifts were induced through raising of the legs or tilting the 
futon on which the subject reclined.  
 
3.3.   Baseline Responses 
 A measurement of changing Hct to diagnose an issue such as internal bleeding 
necessitates an understanding of what normal baseline behavior is and how to recognize 
the same in the PVH output. The Hct is regulated by the body and just like other vital 
signs (e.g. pulse rate, breathing rate, blood pressure and temperature) that exhibit normal 
fluctuations. Filling of the bladder52, insensible fluid loss from respiration53 and 
evaporation from trans-epidermal diffusion54 are a few examples of autonomic processes 
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that cause a slow increase in Hct over time in a patient. These autonomic processes are 
not necessarily constant within an individual or across a population of individuals yet 
normal ranges have been well known for many years.51,53,54 Measuring healthy 
individuals over longer periods of time on many occasions can give a sense of how these 
normal autonomic processes effect the Hct over time. Note that intentional fluid intake 
orally or otherwise would have the opposite effect as systemic fluid loss.  
 Ten different test subjects were monitored for at least 90 minutes each in a total of 
29 experiments to measure the baseline behavior of the Hct over time. Over the course of 
the experiments, it was discovered that allowing the laser to bleach the skin before 
starting the collection would improve the dynamic range displayed as shown in Figure 
3.2. Equations 2.6 and 2.7 from Chapter 2 showed that the PVH algorithm chooses zeroes 
as measured EE and IE from the beginning of the data set. When these zeroes are chosen 
from skin already bleached then the zeroes are a better representation of the subsequently 
collected data. Seven of the baseline experiments were done without pre-bleaching the 
skin and 22 of the experiments were done with pre-bleaching before starting the 
experiment. In order to keep consistency between experiments, the pre-bleaching time 
was set to ten minutes for each experiment. Figure 3.2 demonstrates the difference 
between an experiment that had pre-bleaching and one that did not.  
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Figure 3.2. Measured Hematocrit % over time comparing pre-bleaching to not 
prebleaching of the finger before starting the experiment. Each hemocycle is 3.3 seconds 
and contains 150 averaged 0.02 second frames of data. 
 
 
 The algorithm is designed such that the starting Hct is always exactly 28.35 % 
because we are more interested in changes from homeostasis than in an absolute 
measurement. It is expected that a healthy patient would have a consistent measured Hct 
over time. A percentage change taken as the difference between the starting and the 
ending Hct % across all 29 experiments is 3.41±2.83 %. Taking only the experiments that 
were pre-bleached gives a % change of 2.83±2.05 %. A different method for calculating 
the variability over time, the difference between the highest and lowest measured Hct in 
each experiment, gives 6.72±3.32 % for all experiments. Figure 3.3 demonstrates how 
these two numbers could be so different as the start and end are not always the lowest and 
highest points. Nonetheless an average change of less than 7% from the highest to lowest 
point demonstrates a stable measurement of the Hct over time in a healthy individual. 
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Figure 3.3. Hematocrit % over time on four separate occasions for A) subject 1 and B) 
subject 2. 
 
 As a whole, the baseline data demonstrates stability over time and reveals much 
more information than the standard finger stick method for Hct measurements. Medical 
professionals tend to take Hct values from a finger stick as ±2 units such that a measured 
value of 28% would have a range of 26-30 % for that measurement. Figure 3.3 shows that 
the experiment with the greatest total change is less than 2 Hematocrit units over 90 
minutes and shows details of the smallest physiological increment to about ±0.033 units 
calculated over all 29 baselines (approximately 8 million frames included). That means 
the variability from one measurement to the next is 60 times more precise than the finger 
stick method. We also do better with a continuous real-time measurement and when a 
small section of data is analyzed, additional information believed to be pulse rate and 
breathing rate can be seen as in Figure 3.4. 
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Figure 3.4. Typical one minute of Hematocrit % to show repetitions in the signal. 
 
 Taking a Fourier Transform (FT) of 30 minutes worth of data in Figure 3.4 brings 
out repeating the units seen in Figure 3.5. The two frequency ranges that emerge are from 
0.225-0.23 Hz and 0.95-1.1 Hz. The peak at around 0.23 Hz should correspond to a 
breathing rate ranging from 16-18 breaths per minute, which is in the normal range.55 The 
peak at around 1 Hz would give a pulse rate of about 60-70 pulses/minute which is also 
in the normal range. The 20 second repetitions from Figure 3.4 should be at around 0.05 
Hz which is very noisy in Figure 3.5. We believe this repetition to be the sinus 
arrhythmia (normal range of 3-4 cycles/minute)56 which only appears when the patient is 
quiet and resting but not while talking.    
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Figure 3.5. Fourier transform of 30 minutes worth of data from a baseline spectrum. 
  
Validating the assignment of the 0.25 Hz peak as the breathing rate is as simple as 
purposefully changing the breathing rate which is visible in even the raw data shown in 
Figure 3.6. For the first 100 (5.5 minutes) Hemocycles I kept a normal breathing rate in 
Figure 3.7A. At 100 Hemocycles I switched my breathing pattern to 5 seconds inhalation 
and 5 seconds exhalation for a total of 10 seconds per breath lasting for 100 Hemocycles 
as in Figure 3.7B. At 200 Hemocycles I switched my breathing pattern to 1 second 
inhalation and 1 second exhalation for a total of 2 seconds per breath lasting for 100 
Hemocycles in Figure 3.7C. The breathing time was checked on a watch to keep the 
pattern consistent.  
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Figure 3.6. Screenshot of raw Hct data while changing breathing rate. 
 
 
Figure 3.7. Frequencies of various breathing patterns. A) Normal breathing rate at about 
3.75 sec/breath. B) Slow breathing rate at 10.0 sec/breath. C) Fast breathing rate at 2.0 
sec/breath.  
 
Measuring the plasma volume and Hematocrit noninvasively in vivo reveals a 
plethora of medically relevant information. Plasma volume could indicate fluid shifts and 
potentially be an indicator for dehydration or a full bladder especially in monitoring 
unconscious patients. Hematocrit gives information about the viscosity of the blood and 
could indicate internal bleeding. Patterns in the plasma volume and Hct can also give 
additional information such as the pulse rate and breathing rate from a simple FT. With a 
stable baseline for real time measurements PVH could be a useful tool in many medical 
situations. To our knowledge, there is no other device that can provide so much “big 
data” concerning physiology.  The term “big data” here refers to a measurement of a 
large volume which can be analyzed for patterns or trends. For each 20 msec frame there 
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is a Raman spectrum recorded from which we measure both the EE and IE to calculate 
RBC volume and plasma volume for the Hct. Trends in the PV and Hct can then be 
analyzed for the pulse rate and breathing rate to give a larger data set than just one point 
of data per measurement. 
 
3.4.   Pressure Effects 
 The PDPM, discussed in Chapter 1, was developed to give a patient visual 
feedback about contact and pressure against the probe. While the current model of finger 
probe was not designed to be used with a PDPM, the pressure of the probe against the 
finger can have an effect on the measured spectra. When a finger is pressed against the 
aperture of the probe the skin extrudes into the aperture. If the pressure is not sufficient 
there is little extrusion into the aperture which may cause the focus of the laser to not 
converge in the capillaries. Conversely, if the finger exerts excess pressure against the 
aperture it can impede the flow of blood through the capillaries (i.e. cause occlusion 
which results in pooling of RBC’s at the site of the probe) and a red dot is visible in the 
skin in the center of the aperture.  
 “Human factors” is a broad term used to describe how a patient can either 
purposefully or inadvertently cause errors in the collection of data. Imagine a patient 
sitting in a chair at the doctor’s office with a probe attached to one finger who, without 
thinking, pushes down on the armrests of the chair to adjust his posture. Pressing against 
the armrest with the probe would cause a greater pressure against the aperture which 
could trap RBC’s giving a temporary spike in the measured Hct. With this in mind we set 
out to measure the effect of intentional increases in probe pressure to the measured Hct. 
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 An experiment was designed where each patient would press on the probe and the 
opposite side of the finger to increase the pressure of the finger against the aperture of the 
probe. The patients were asked to start pressing on the probe at 30 Hemocycles and hold 
until 35 then release. At 60, 90 and 155 Hemocycles the patients were asked to press and 
hold for 10 Hemocycles each time. The procedure was repeated for each patient on three 
different fingers to avoid placing the probe on a spot that had been previously bleached or 
partially bleached. This experiment took place before the procedure of pre-bleaching the 
skin was implemented so the bleaching can be seen at the beginning of each 
measurement. Four patients were asked to repeat this procedure on three different fingers, 
which is shown in Figure 3.8.  
 
Figure 3.8. For each Hemocycle (3.3 seconds) the Hematocrit % was measured in each 
patient.  The procedure stated that each patient should be pressing on the probe from 30-
35, 60-70, 90-100 and 155-165 Hemocycles. Each patient attempted to replicate the 
procedure on three different fingers.   
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 The data in Figure 3.8 shows that subjects 2 and 4 were able to consistently 
increase the measured Hct by pressing on the probe. Subjects 1 and 3 were able to 
increase the measured Hct only some of the time. The manner in which the pressure is 
applied may play a factor in the change to the Hct. For example, subject 3 had drops in 
Hct for two of the pressure increases with the middle finger experiment. It is possible that 
applying unequal pressure to one side of the aperture could cut off flow of RBC’s 
entering the tissue extruded into the aperture while allowing outflow which would show a 
decrease in Hct. A medical term called turgor describes the ability of the skin to return to 
the original shape after it has been pressed in. The turgor often decreases with age but it 
is possible for a younger person to have poor turgor. 
 In the development of the PDPM, variability in level of compliance from a human 
subject was observed.14 Giving the subject explicit directions and detailed feedback does 
not guarantee that the subject is capable of successfully performing the task repeatedly. 
Of the four test subjects only two were able to apply adequate pressure to reliably cause 
an increase in the measured Hct. The results demonstrate the apparent increase in 
measured Hct when an applied pressure traps RBC’s in the skin extruding into the 
aperture of the probe but that the reproducibility is dependent on the compliance of the 
subject.  
 A different approach to changing pressure internally instead of externally is a 
standard medical procedure called the Valsalva maneuver which can be explained as 
attempting to push air against a closed orifice.29,30 It is actually a very nuanced procedure 
involving many details in exactly how a given maneuver is executed. A common example 
of this occurs on an airplane with a sudden change in altitude when a passenger may hold 
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their nose closed and attempt to blow air from the closed orifice to clear sinus fluids that 
impair hearing. The act of pushing against a closed orifice requires flexing of the 
diaphragm to increase pressure within the abdomen and that impedes the return of venous 
blood to the heart, resulting in decreased cardiac output. When attempting to rationalize 
the Hct and plasma volume changes recorded during any perturbation from homeostasis 
there are two necessary rules. First, the RBC’s only move when the plasma pushes them 
and, second, the plasma always moves first.   
Figure 3.9a shows the characteristic response of a Valsalva maneuver in both the 
plasma volume and the Hct when the procedure is initiated with an exhalation.57,58 The 
initial abdominal pressure increase at around 7 seconds produces a push of plasma before 
the continued pressure (i.e. diaphragm expansion) decreases the amount of blood 
reaching the heart from the femoral venous return. The RBC’s motion always lags the 
plasma flow; the RBC motion is caused by the plasma flow resulting in an increase in 
measured plasma volume and decreasing Hct in the periphery at the earliest stages of the 
procedure. When the Valsalva maneuver is released at around 47 seconds the flow of 
RBC’s is restored and the Hct increases quickly followed by a decrease in plasma volume 
which may indicate that the increase in RBC’s serves to block flow of the plasma 
momentarily. After a few seconds the PV and Hct return to their original levels at 
homeostasis. Figure 3.9b demonstrates that a Valsalva maneuver starting with an 
inhalation gives a different response which causes a rise in the Hct rather than a decrease. 
Inhalation serves to inflate the lungs which further decreases the venous return causing 
the drop in plasma volume and apparent increase in Hct.   
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Figure 3.9. Measured plasma volume and Hematocrit during a Valsalva maneuver 
beginning with a) exhalation and b) inhalation. The vertical lines indicate the beginning 
and the end of the Valsalva maneuver in each experiment. 
 
 The Valsalva maneuver serves as a standard test to observe characteristic changes 
to both the plasma volume and Hct in real time. The Chaiken lab first published the 
measured Hematocrit during a Valsalva maneuver in 2012 along with Figure 3.10 which 
was reprinted from Wikipedia with permission.21 Starting the Valsalva maneuver with an 
inhalation before applying pressure gives the plasma volume from Figure 3.9b a similar 
shape to the systolic blood pressure from Figure 3.10 making it likely that the Valsalva 
maneuver performed in Figure 3.10 started with an inhalation. Both the plasma volume 
and Hct behave as would be expected for both the inspiratory and the expiratory VM. 
 
Figure 3.10. The textbook physiological response of pulse rate and systolic blood 
pressure to execution of the Valsalva maneuver (taken from Wikipedia with permission). 
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3.5  Postural and Orthostatic Induced Fluid Shifts 
 Applying either internal or external pressure is one way to observe changes in the 
PV and Hct but one could also change the orientation of the body to induce orthostatic 
redistribution. Section 3.3 showed data where individuals laid in the horizontal position 
for baseline responses but we should be able to observe the blood moving as the legs of a 
patient are raised. Figure 3.11 shows the results of 6 separate experiments executed over 
a 3 month period involving a single, healthy male test subject aged 60. Each experiment 
was initiated by the test subject placing the probe on the middle finger of the right hand 
and pre-bleaching the location for 10 minutes while either sitting or lying supine on the 
cot. After the pre-bleaching procedure the test subject assumed the supine position, if not 
already in that position, and data collection began. For all of the orthostatic redistribution 
experiments (top) the pre-bleaching was done in the supine position but for 2 of the 3 
pure baseline experiments (below), the subject was sitting while bleaching, and then 
became supine just before PVH data collection began. For these experiments, the Hct can 
be seen to increase faster at the outset of the experiment than later. Thus each data 
collection began with the subject supine, motionless and speechless and all data sets in 
Figure 3.11 extended continuously for 2 hours with PVH measurements being taken 
continuously at 50 samples/sec. When the time scale is in “Hemocycles” the raw data has 
been averaged to produce readings every 3 seconds in order to mimic what a practitioner 
would see if she/he were observing the PVH output with a 3 second refresh time. Earlier 
experiments showed that speaking and wakefulness is reflected by a more chaotic data set 
while a sleeping subject always produced very periodic fluctuations in PVH and Hct.  
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Figure 3.11. Top: 3 trials with the same test subject where the legs are raised and 
lowered where indicated. Bottom: 3 trials with the test subject lying flat with no 
perturbation. 
 
For the upper data sets, at the times indicated by the arrows, a lab assistant raised 
the legs of the test subject and placed them on a large, firm, vaguely cylindrical support 
pillow so that the test subject was relaxed in a near lithotomy position. As shown in 
Figure 3.12 in all cases the plasma volume immediately increased/Hct decreased reaching 
a peak/minimum in ≈20 seconds before slowing increasing back to the original level, 
which is roughly where it appeared it would have been in the context of the 
“background” fluctuations that were occurring when the postural/orthostatic perturbations 
were initiated. Background fluctuations appear to be of two types 
systematic/deterministic and random. Deterministic fluctuations were identified because 
their appearance and frequency was related to the probe pressure at the skin. When the 
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legs were lowered and the subject resumed the supine position we also see a smaller but 
clear repetition of the earlier behavior wherein the plasma volume increased immediately 
with the Hct changing in a complementary manner. 
 
Figure 3.12. Expanded scale from Figure 3.11 showing speed of fluid movement for 
topmost trial with legs being elevated. 
 
We also performed the same experiment but instead of the subject visiting the 
lithotomy position, a tilt table was employed such that at 200 Hemocycles the subjects 
feet were elevated to approximately the same height as for Figure 3.11 but the hands were 
also elevated. In this case we observed similar overall effects involving an immediate 
change in PV with each orthostatic transition but now the PV immediately fell with 
elevation before increasing again after removing the tilt. Although 2 hour experiments 
were also performed, for purposes of producing Figure 3.13 in a 30 minute experiment, 
we also employed an automatic blood pressure cuff (Omron) on the right arm (opposite 
of the PVH) allowing us to record blood pressure and pulse rate throughout. There appear 
to be correlations between the action of the cuff on the left arm and the PVH 
measurements on the right finger tips.  
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Figure 3.13. Tilt table elevate legs 14 degrees at first arrow, return to 0 degrees incline at 
second arrow. PVH measured at right middle fingertip and BP cuff on left arm.  
 
 
The lithotomy position in places the legs in such a position that only fluid can 
flow from the legs into the mid and upper torso. Figure 3.11 shows Hct decrease as the 
legs are lifted. In this position since the arms and hands are at the same level as the rest of 
the torso, the increase in plasma volume occurs sharply and has a slow decrease 
presumably as the RBC’s catch up later. One might imagine that interstitial fluid could 
eventually move also but this cannot be discerned uniquely from the present experiments. 
The tilt table experiment depicted in Figure 3.13 is different from the lithotomy 
position experiments in that the arms and hands are also elevated relative to the upper 
torso and so when the elevation occurs, the hands and arms are also elevated and the net 
fluid flow should be outward as observed. When the tilt is removed the arms and hands 
become level with the upper torso and so the plasma volume should increase as upper 
torso fluids flow into and through the arms and hands as observed. It is interesting to note 
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that the deterministic fluctuations are continuous and the other effects are essentially 
superimposed on top of them. We consider this observation as further proof that the 
probe sensitive fluctuations are due to the interaction of the probe aperture with the 
capillaries.  
The tilt table experiments that included the blood pressure cuff monitoring in 
Figure 3.13 suggest that, at least in the no elevation/supine position, perturbations in 
overall blood flow indicated by the mere presence of blood pressure/pulse rate 
measurements can be observed by the PVH device on the opposite arm. We have 
certainly seen an effect on plasma volume and Hct before when the pressure 
cuff/tourniquet were on the same arm but we had not done the experiment before in the 
supine position. Similarly we note that on a number of occasions in Figure 3.13 (e.g. 
between about 140-250 seconds) the diastolic blood pressure appears to track the plasma 
volume. Since the intravascular plasma is what transmits the blood pressure, and the 
background plasma volume is present during diastole, this seems reasonable. Between 
about 275 and 400 seconds there are 7 cycles of deterministic fluctuation and these are 
uninvolved with the blood pressure measurements, again supporting the idea that these 
are due to local probe induced effects. 
Since the algorithm directly calculates the plasma volume and RBC volume, we 
could have reported those two parameters as the basic result of these experiments. We did 
not do that because they track each other very closely and small changes are not easily 
seen. We propose that plasma volume and Hct are the more useful parameters because 
Hct is a well-known physiological parameter and plasma volume may be the more useful 
“vital sign” given its potential connection to blood pressure. The calibration of the PVH 
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to the CRIT-LINE chooses a-f that yield the expected result. Additionally, the CRIT-
LINE only actually measures Hct from that, with assumptions of normality and total 
blood supply the plasma volume is calculated. The behaviors of the subsequent raw data, 
however, could easily cause this procedure to produce meaningless or even unphysical 
results if this entire analysis were erroneous. It may be an assumption of the model but 
there is no mathematical constraint on the application of the algorithm for either Hct or 
plasma volume to assume a certain range of values or to be complimentary. As noted 
above, the two parameters are calculated from two independent equations and if the raw 
data were not internally consistent, any calculated result is possible. This suggests that if 
there was loss of either plasma or RBC’s from the intravascular space, the algorithm 
would produce a consistent result.  
 
3.6.   Summary 
 Establishing a baseline response in the plasma volume and Hct affords a 
definition of what constitutes normal so that abnormal can also be defined. The human 
body is incredibly complex with many systems running in unison to keep homeostasis 
and the state of homeostasis itself undoubtedly varies somewhat from person to person. 
Thus we find it more useful to define a set of zeroes at the beginning of the monitoring 
session for each patient and observe changes from that starting point. We have 
established with many hours of baseline data on multiple patients that the Hematocrit 
calculated by this algorithm is very stable. From one point to the next the smallest 
physiological increment is only ±0.033 Hct % variability and over the course of about 
two hours the average difference from start to end was within ±1.0 Hct %. Compared to 
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the standard finger stick method of Hct measurements, in which a measured value of 29 
% would mean it is in the range of 27-31 %, the PVH algorithm is able to monitor small 
and systematic changes.  
 A medical device used to monitor the Hct noninvasively in vivo would also 
greatly benefit from simultaneous monitoring of other vital signs. By taking a Fourier 
Transform of the measured Hct, the frequencies for the pulse and the breathing rate are 
observed. The FT analysis is a convenient means for averaging time dependent data over 
a specific interval to simultaneously show not only the pulse rate but also the breathing 
rate. One could imagine many clinical settings, such as patient monitors in hospital rooms 
where an output of Hct, plasma volume, pulse rate, and breathing rate would be 
beneficial to the medical staff. For example, the breathing rate could be used remotely to 
monitor if a patient is awake or sleeping based on a different breathing rate or temporal 
pattern54 or it could help diagnose some sleep disorders such as sleep apnea. The 
behavior of the plasma volume and Hct signal the transfer of fluids between 
compartments including the onset of dehydration and kidney function.   
 We have purposefully chosen experiments which require minimal movement 
because of what we call the motion defect. Figure 3.3b shows the motion defect in the 
green trace at around 725 and again at around 900 Hemocycles which looks like the 
spectrum makes a major jump over one Hemocycle. The motion defect is from 
mismatching fiber optic diameters such that a motion of the cord can change the amount 
of light reaching the detector. This is a problem that is easy to fix but would also require 
recalibration. For that reason, fixing the motion defect has been delayed to keep 
measurements consistent throughout and to make the most from this round of 
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development. As such, the variations calculated across all of the baseline data includes 
the motion defects, meaning that the 0.033 Hct % variation between measurements would 
surely be lower.  
 There is also the issue of pressure and specifically the pressure of the skin in 
contact with the probe. The skin extrudes into an aperture in the probe and the pressure of 
the contact dictates how far the skin extrudes into the aperture. If there is not enough 
pressure, the skin extrudes very little into the aperture and the focal point of the laser is 
not focused into the capillaries. If the pressure is too high, the flow of the capillaries can 
be impeded and there can be irregularities in the data such as pooling of the RBC’s in the 
extruded tissue. The next design of the finger probe would benefit from a system that 
controls the contact pressure.    
 Despite a couple limitations in the current design of the instrument, the measured 
Hct is stable over long periods of time and shows movement from known physiological 
responses. The Valsalva maneuver shows textbook responses and also demonstrates how 
the PVH algorithm responds to changes in the blood. Postural changes can also be used to 
observe characteristic fluid redistribution. These changes would be lost in the noise of 
contemporary Hct measurements yet they are distinct changes observable directly from 
the out of the PVH instrument.  
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4. PVH Measurements in a Rat Model 
 
4.1.   Motivation for Use of Rat Model 
In trauma and emergency medical situations, as commonly occur in the military 
and civilian worlds,19,20 determining 1) whether a person is bleeding internally and if so 
2) the location and rate of that bleeding can be the difference between life and death. In 
the Golden Hour after injury, insuring the integrity and function of the cardiovascular 
system is essential but autonomic compensation for the loss of fluid from the 
intravascular space can delay diagnosis and, consequently, treatment. Compensation 
causes changes that begin before the patient is in danger (e.g. during a routine blood 
donation). As bleeding continues, changes in blood composition occur in response to 
changes in intravascular pressure. Eventually reserve RBC’s and protein from the spleen 
and liver enter the intravascular space, altering the Hct and the oncotic balance between 
interstitial fluids and the blood plasma, and extending the time before circulatory 
collapse. The goal of this research was to determine if pressure and compositional 
changes can be detected noninvasively and in vivo in a rat model.  
This chapter focuses on monitoring relative changes in Hct and plasma volume 
that accompany blood removal and fluid replacement in a rat model in order to learn how 
to use them as “vital signs” to diagnose, locate and treat internal hemorrhage in humans. 
We report experimental details specific to rats since all of our previous in vivo results 
have involved only humans.21 The results of blood removal-fluid replacement 
experiments are shown in terms of the variation in plasma volume and Hct in response to 
specific stimuli.  
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4.2.   Experimental 
All procedures performed using animals were conducted under IACUC approval 
at Syracuse University (Appendix B). The spectroscopic measurements employed a 
modified commercial Raman Spectrometer (Lambda Solutions, Waltham, MA) and a 
specially designed probe intended to mimic the type of aperture-orifice described in 
Chapter 3 in the context of human monitoring. The probe comprises a 2 mm ID tube with 
a 2 mm flat lip containing a lens placed near the end of the tube such that when the tube 
is pressed against the skin, the light is delivered to the skin protruding into the hole at 
approximately f=2.0. The delivery and collection is symmetric so the collection is also at 
f=2.0 with an approximate 150 µm diameter spot size. The rest of the optics and filtering 
is standard for Lambda Solutions probes but there is an additional Raman notch filter 
(Semrock, Rochester, NY) placed between the collimating lens and the grating to allow 
adjustment of the EE and IE for optimum dynamic range.  
The rats used in this study were Sprague Dawley® which were pre-cannulated 
(right jugular) to reduce stress on the animals from multiple procedures drawing blood. 
The animals were fully anesthetized with a ketamine/xylazine mixture and allowed to rest 
on a heating pad for all procedures regardless of if blood was drawn or not. A schematic 
of the blood removal site and the monitoring site of the rats is given in Figure 4.1.  
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Figure 4.1. Schematic depiction of the site of monitoring and the site of blood removal 
via the right jugular vein. In all data shown the blood is removed from the left carotid 
artery. Fluid replacement involves either the same whole blood initially removed or 
NormoCarb, an electrolyte replacement fluid commonly used for fluid replacement 
during dialysis. (In accordance with Creative Commons License the animal drawing is 
adapted from http://www.biologycorner.com/resources/rat_circ_vein.gif  ) 
The measurement process used an improvised platform (base from Lambda 
Solutions) that allows us to know how the pressure between the probe and the tissue 
varies in time and whether there is gross motion. Blood is very responsive to externally 
applied pressure. Data interpretation utilizes the probe-tissue pressure changes during 
monitoring blood removal and fluid replacement. Having tried ears, tails, belly and front 
and back paws we chose front paws as the preferred site. The paw is placed between the 
probe and rubber bulb shown in Figure 4.2 and the pressure in the bulb is measured by a 
capacitance manometer. If there is motion of any kind or if there are internal pressure 
changes, it is recorded in the digital record provided by an AD Instruments Power 
Amp/data logger. That record, combined with direct observation, allows differentiation 
between movement and internal pressure fluctuations. An example of the baseline 
behavior of the plasma volume and Hct for a rat with no blood removal and fluid 
replacement is shown in Figure 4.3.  
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Figure 4.2. Lambda Solutions probe mounted on microscope base with probe contacting 
a latex bulb whose internal pressure can be monitored. The rat paw is placed in between 
the probe and bulb, palm up.  
 
 
 
Figure 4.3. Typical baseline behavior (20 msec per data point) of plasma volume and Hct 
and spontaneous variation in probe pressure during course of an experiment in which no 
blood removal or fluid replacement occurred. The variation in probe pressure is due to 
the response of tissue to recover homeostasis compared to the state before the probe was 
applied as well as systemic changes due to onset of anesthesia and sedation and near the 
start of monitoring at 33 minutes, bleaching of tissue autofluorescence. (capacitance 
manometer is MKS Instruments, Andover, MA) 
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4.3.   Results 
The results of all experiments were qualitatively identical and internally 
consistent after 54 separate procedures, some involving baseline measurements and some 
involving blood removal and fluid replacement, involving 20 different rats. The 
responses that will be shown below can therefore be considered typical however, as we 
learned with human studies,14 better reproducibility results from achieving more 
reproducible probe placement and pressure. Since we learned that there is a reproducible 
baseline behavior as shown in Figure 4.3 we were able to design a series of experiments 
to be executed over a few weeks with a single rat in which a baseline response for that 
specific rat could be obtained and then used to help interpret the behavior for the same rat 
in later blood removal-fluid replacement experiments. Since the baseline behavior 
depends on the age and weight of the rat and dosage of the ketamine-xylazine 
combination used, having recent rat specific baseline data allowed subtraction of the 
baseline responses to better compare quantitatively, the device provided Hct and plasma 
volume responses to the known blood removal and fluid replacement. We have termed 
this subtraction “orthostatic correction” because it involves the redistribution of blood 
and other fluids to placing the rat in the monitoring platform immediately after anesthesia 
is administered and the animal is adjusting. It must be emphasized that the Hct and 
plasma volume changes shown below could all be seen in real time without any such 
correction and we shall show one such data set below.  
Over a 3 week period, the same rat was used to obtain 1) a baseline response 
which involved no fluid replacement/removal at all, 2) a response involving major blood 
loss followed by replacement with whole blood, and 3) a response involving major blood 
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loss followed by replacement with Normocarb. Correcting the response of the two 
replacement experiments using the baseline response allows observations.  
According to the results produced by the algorithm some general observations can 
be made. First, removal of whole blood always results in a decrease of Hct and increase 
of plasma volume. The decrease in Hct depends on the rate of blood removal and the 
amount removed. Second, fluid replacement using whole blood, as seen in Figure 4.4, 
results in an increase in Hct whereas, third, straight Normocarb replacement, as shown in 
Figure 4.5, produces a more muted response due to an increase in the number of RBC’s 
into the intravascular space. Note that all observations were visible in real time without 
the baseline correction. 
 
Figue 4.4. Behavior of Hct with fluid replacement using whole blood replacement after 
whole blood removal. Annotation gives timescales and amounts of removal and 
replacement. 
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Figure 4.5. Behavior of Hct with fluid replacement using Normocarb after whole blood 
removal. Annotation gives timescales and amounts of removal and replacement. 
 
 Figure 4.4 shows the sizes of the observed fluctuations as a function of the 
accumulated amount of blood removed at least as much as the amount actually removed 
at a single moment. That is, removing an additional mL after 2.4 mL removed produces a 
different Hct response than the first mL removed. In humans we expect Stage 2 
compensation to begin after removing about ≈15% of the available blood supply which 
corresponds to about 2.4 mL for a 225 g Sprague Dawley rat. Since we use one set of a-f 
parameters obtained from human data and the EE0 and IE0 are set for each rat at the 
beginning of each monitoring run, we do not necessarily accept the actual numerical 
values of the Hct change or the plasma volume change due to blood loss at this point only 
because it cannot be independently confirmed. Presently we can report that the observed 
changes are very small and reproducible. 
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Figure 4.6 documents removal of blood from a large vessel at bleeding rates of 
roughly 15-20% of total blood (about 16 ml) in 2-3 minutes and the results clearly show 
that the effects are discernable from normal background homeostatic variations. The 
plasma relates to blood pressure since the intravascular space must be filled in order to 
support pressure. Stage 1 compensation for blood loss includes constriction of the 
vascular bed maintaining the internal pressure when the intravascular plasma volume is 
reduced by blood loss. Thus the apparent plasma volume increases since the available 
intravascular volume itself is decreased. 
 
Figure 4.6. The real-time raw behavior of Hct and plasma volume to blood loss removal 
from carotid artery with no fluid replacement is shown without orthostatic correction. 
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inject it. Nevertheless there is a clear response that we assume involves the flushing of 
fluorescent materials from the intravascular space into the interstitial space. 
 
Figure 4.7. Response of Hct and plasma volume to 2 injections of Normocarb (2 mL 
each) starting at 200 and 400 hemocycles without prior blood removal. 
  
4.4.   Summary 
The new algorithm clearly presents a new approach to monitoring blood 
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force. Thus the algorithm is calculating a number that increases with both Hct and Hgb 
but may not be physically related to either exclusively. This idea is consistent with the 
fact that a strong correlation between the noninvasive measurement of either Hct or Hgb 
using Twersky and the invasive finger stick Hgb (such as HemoCue or conventional 
centrifuge) Hct measurement is well established. But to our knowledge in the literature, 
credible approaches50,51 to either noninvasive measurement produces Hgb or Hct that has 
≈8.3 % error compared to either conventional measurement. This is apparently not 
sufficiently sensitive, accurate or precise to provide the type of information that medical 
practitioners need for our intended use48. Conventional measurements47 are often less 
precise and accurate than either the noninvasive measurements due to sampling error and 
errors in sample handling.  
Why is the present algorithm more sensitive? Except for probing geometry, one 
channel of the algorithm described in Chapter 2 is that the EE is identical to one channel 
of nearly any photoplethysmographic device. Most photoplethysmographic devices work 
in a trans-illumination geometry in which the effects of multiple scattering cannot be 
avoided. In the approach described herein we avoid multiple scattering by choosing an 
excitation-collection geometry that minimizes collecting light that has penetrated too 
deeply into the tissue. This gives the present approach an advantage that is analogous to 
the advantage in vitro nephelometry enjoys over in vitro turbidometry59. Nephelometry 
allows a roughly 2-3 order of magnitude decrease in the detection limit for any directly 
comparable turbidometric approach. For all turbidometric cases we are measuring a 
relatively small change on a large background signal that is comparable with the shot 
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noise for the background. There is no background in nephelometry and there is no signal 
at all unless scattering occurs. 
The IE is even more immune to background noise since it is so easy to separate 
from the probing light. The absence of a background for either the EE or the IE causes 
the present algorithm to be intrinsically more precise and accurate in the same sense that 
fluorescence is superior to absorption based measurement systems.48 The present 
approach uses a single light source to probe the tissue and the Twersky based approach 
uses 2 light sources, and their mutual overlap in the tissue volume is not necessarily 
unchanged as Hct and plasma volume change. Fundamentally, the absorption based 
approaches such as Twersky’s are ideal for oximetry (SPO2) because of the existence of 
convenient isosbestic points for oxy-deoxy Hgb. They are less successful for Hgb or Hct 
measurement because the net probed volume absorption is dominated by hemoglobin. As 
suggested by Table 1 the absorption measurement approach is not sufficiently sensitive to 
the blood fluid (e.g. the water based phase, plasma). Even at 947 nm the absorption of 
water in blood plasma cannot apparently be differentiated from interstitial water based 
fluids.  
The interstitial fluids do not fluoresce to the same extent as blood plasma. Plasma 
contains more substances than interstitial fluid. The latter composition is dominated by 
the presence of small organic molecules and electrolytes. These additional primarily 
protein components appear to contribute a greater fluorescence per unit volume to 
plasma. Therefore the IE has a significant contribution from plasma in addition to that 
from hemoglobin. The relative contributions of these two sources can be adjusted 
somewhat by choice of excitation wavelength but the effect of Hgb oxygenation is 
67 
 
 
noticeable when 830 nm excitation is used. In this study 830 nm provided a good balance 
between plasma fluorescence and hemoglobin fluorescence but a small oxygenation 
“defect” was observed. 
We have presented data from blood removal and fluid replacement experiments 
involving a rat model and a new algorithm intended to calculate relative Hct and plasma 
volume changes. The data suggests that the algorithm actually calculates the intended 
physical parameters and that bleeding and fluid replacement may be observed with 
sufficient sensitivity and stability to allow timely diagnosis, location and treatment of 
hemorrhage. More study is required but this algorithm may be a significant improvement 
over photoplethysmographic technologies.  
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5. in vitro Model to Validate the PVH Algorithm 
 
5.1.   Background 
Chemical analysis of turbid samples60 without the need for physical sampling, 
pre-filtration or equivalent sample preparation is always desirable. For example, algae-
based biofuel production has received much attention61,62,63,64,65 as a more 
environmentally friendly renewable energy source. To manage oil production from algae, 
it will be necessary to monitor the growth of algae in the growth medium before 
processing. To avoid contamination or other perturbation of the culture it would be 
advantageous to avoid direct physical sampling. Vibrational spectroscopy in combination 
with standard chemometrics allows determination of the levels of nutrients and metabolic 
waste materials in the growth medium of PC-3 human prostate cancer cells66 but only 
after filtering the cells out of the medium. 
The determination of the viability of bacteria, yeast, algae or stem cells in a 
growing culture would benefit from a noninvasive procedure. Each involves 
determination of the volume fraction of a highly scattering phase within the algae, 
bacteria, yeast, stem cells or debris, dispersed in a homogeneous second phase that 
produces Raman and/or fluorescence emission, in addition to Rayleigh and Mie scattered 
light. With NIR light the probing is almost always nondestructive but there are other 
potential applications where this algorithm could be applied using UV-visible or other 
light for probing noninvasively. 
A number of groups67,68,69,70 are interested in similar problems and calculate the 
effect of the turbidity on some spectral property such as spectral distortion of remitted 
emission or absorption spectra where the emission can be fluorescence or Raman. The 
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radiation transfer equation can be used, as can Monte Carlo approaches depending on the 
importance of multiple scattering effects in the measurements and the desired goals. One 
could use various calibration approaches combined with chemometric techniques such as 
principal component analysis or partial least squares on corrected data to obtain absolute 
concentrations. Absorption-based approaches68 often focus on associating a meaningful 
pathlength to spectra of turbid samples. 
Ancillary measurements are sometimes proposed67 wherein diffuse reflectance 
can be combined with Raman to give turbidometric or nephelometric information for a 
calibration model. The measurements would have to be made simultaneously to provide 
quantitative algorithmic input for the spectroscopic correction. If turbidity-corrected data 
can be obtained, a variety of approaches can be tried. Warner and McGowan71,72 have 
used multiple excitation wavelengths with multiple emission wavelengths to analyze 
multi-component mixtures. Choosing a specific approach for a specific goal will depend 
on the specific properties of the system in question but there has been considerable effort 
directed at finding new and clever approaches to compensate for turbidity in 
spectroscopic probing of matter. 
We encountered this problem in the noninvasive in vivo probing of tissue14,34 
using a single NIR laser.  For that situation the remitted light was easily partitioned into 
two components: one that seemed to be mostly affected by turbidity effects and another 
that was mostly related to the chemical composition of the volume probed. Given our 
specific goals6 we used the radiation transfer equation34 to model irradiation of the outer 
layers of skin and collection of remitted light in our specific geometry and found that we 
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could account for our observations with a model that considered only singly scattered 
light explicitly. 
In fact, from the published35,36 absorption and scattering coefficients of the main 
components of the probed medium—red blood cells, plasma and skin cells—given in 
Table 2.1, it could be shown34 that single scattering dominates such as the scattering 
length for the highest blood perfusion and for the expected range of Hematocrit is longer 
than the distance from the outside of the skin to the nearest outer capillary loops. Thus 
the region between the outside of the skin and the outermost capillary loops is optically 
thin. Furthermore, the experimental conditions for a relatively small f number for the 
incoming light are such that, based on Monte Carlo simulations of similar probing70 the 
collected light from offset=0 relative to the light entry point will be mainly >90% from 
the nearest subsurface region. This region is defined by the prevailing scattering length 
and so, when probing most if not all skin with NIR, the collected Raman or fluorescence 
is in fact dominated by single scattered light. This was also indicated by numerical 
radiation transfer equation simulations.34 
To demonstrate the generality of our approach and support future applications in 
which the goal is to quantitatively monitor chemistry in situ in turbid media or the spatial 
homogeneity of the turbidity of a sample, this chapter applies it to a well-defined model 
system. It comprises particulate scattering centers dispersed in a less strongly scattering 
but fluorescent or Raman active surrounding medium. Quantitative determination of a 
fluid-based concentration and the relative phase volumes of the fluid and particulate 
phases requires simultaneous accounting for turbidity and spectroscopy. First we 
introduce the algorithm for two-phase systems.  In particular, we show why volume 
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fractions are linear functions of IE and EE. Then we describe the in vitro system on 
which measurements were made and show how the results support the theory. This 
system has some features of the blood system, such as spatial inhomogeneity and light-
induced solution chemistry. The latter mimics the well-known autofluorescence and 
bleaching effects of NIR probing of tissues and biological media in vivo. 
 
5.2    Theory 
We now develop the model for our system to indicate when the assumed linear 
dependences are likely to be valid and provide insight into the behavior of the IE and EE 
when the assumptions of the model are not met experimentally. The predictions of the 
model are then checked against experimental results for a system of quartz spheres 
suspended in an aqueous medium. The EE and IE will be linear functions of one volume 
fraction and one concentration, instead of two volume fractions. 
A beam of radiation, with intensity I, starts from a source in layer 1 (vacuum), 
located at x = 0, y = 0, z = b; it propagates in the x-z plane and enters the 2nd (2-phase) 
layer at x = b tan 1, y = 0, z = 0, where it changes direction because of Snell refraction 
(see Figure 6.1). Layer 2 is infinite in the x- and y- directions, and bounded by the planes 
z = 0 and z = h. The beam is attenuated as it moves downward through layer 2. At any 
point along the beam (circle in Figure 5.1), elastic and inelastic scattering may take place 
(they contribute to the intensity attenuation). The scattered radiation is assumed to be 
spherically symmetric, so some of it (long-dashed line in Figure 5.1) is scattered in a 
direction such that, after Snell refraction at the surface, it hits the detector (of course the 
scattered radiation beam is also attenuated in the medium). The detector is parallel to the 
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x-y plane and centered at x = X, y = 0, z = c. Along the x-direction, it extends from 
Xd/2 to X+d/2; along the y-direction, it extends from –f/2 to +f/2. 
 
Figure 5.1.  A beam of intensity I originates at the source (x = 0, z = b), passes through 
the upper phase, is refracted at the phase boundary, and propagates (with attenuation) 
through the lower phase (dashed line). At any point on the beam (circle), a spherical 
scattered wave is produced, part of which (long-dashed line) reaches the detector at z = c, 
x = X.   
 
Layer 2 involves two phases, denoted by a and b, with the volume fraction of a 
equal to , so the volume fraction of b is 1. Let the absorption coefficients for the two 
phases be a and b, the elastic scattering coefficients be a and b, and the inelastic 
scattering coefficients be a and b. Then for a beam with intensity I, the absorbed 
intensity per unit volume is I[a+(1)b], the elastically scattered intensity is 
I[a+(1)b], and the inelastically scattered intensity is I[a+(1)b]. The total 
attenuation coefficient  is 
   = (a + a + a) + (1)(b + b + b)  [5.1] 
so the intensity of a beam decays exponentially according to    
    I(r) = I(0) er     [5.2] 
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where r is distance along the beam direction. This applies to the incoming and scattered 
radiation.    
The beam starts at x = 0, z = b and enters the condensed phase at x = b tan 1, z = 
0 (see Figure 5.1). The angle 2 is calculated by Snell’s Law. Since n2> n1, sin 1 / sin 
2>1 and 1>2. Then, a distance r down the beam, we reach the point x = b tan 1 + r sin 
2.  If I is the initial intensity, the intensity here is I er. The elastically scattered 
radiation (outgoing spherical waves) has intensity proportional to  
   I er [a+(1)b]    [5.3] 
(independent of direction), and the inelastically scattered radiation is given by a similar 
formula with  replacing . The ray of interest is the ray that exits the condensed phase 
after passing through a distance r* (see Figure 5.1), changes direction at the surface, and 
hits the center of the detector, which is at z = c, x = X. If the exit point is z = 0, x = xe 
then  
   (X  xe)/c = tan 1*    [5.4]   
and 
  (xe r sin 2 b tan 1)/r* = sin 2*   [5.5]   
The intensity is reduced by a factor er* (the distance traveled in phase 1 is unimportant 
since there is no attenuation of the beam in this phase). 
Only radiation deflected into the detector by a single scattering event is 
considered explicitly. There is a possibility that some of the scattered radiation undergoes 
another scattering event which changes its direction so that it never reaches the detector; 
this reduces the detected intensity. There is also a possibility that radiation scattered from 
the incoming beam, in a direction which would not allow it to reach the detector, 
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undergoes another scattering event which changes its direction so that it does reach the 
detector; this increases the detected intensity. These double-scattering trajectories are 
much less likely than the single-scattering trajectories we consider, since the scattering 
length is large compared to the dimensions of the system. Furthermore, the contributions 
of the two kinds of double-scattering trajectories to the detected intensity partially cancel.  
For these reasons, in this geometry btanxe being small or stated differently that the 
spatial offset between where the ray enters and where it exits approaches 0, neglect of 
explicit consideration of multiple-scattering events can be a very good approximation. As 
supported by Monte Carlo simulations11, the larger is btan-xe the greater the contribution 
of multiple scattered light to the total remitted light. Note that here multiple scattering is 
considered in an average way, through the attenuation coefficient. 
We require an expression for r* in terms of r. Combining the above equations, we 
get 
 r* sin 2* = X  c tan 1*  r sin 2 b tan 1  [5.6] 
where     
r cos 2 = r* cos 2*     [5.7] 
Thus we start from 1 (given by the experimental set-up), and calculate 2 using Snell’s 
Law: n2/n1 = sin 1 / sin 2 = sin 1* / sin 2*. Then the equations [5.6] and [5.7] allow 
calculation of 2* and r* for any r. Equation [5.7] is rewritten as  
  sin 2* = √1- (
r cos θ2
r*
)
2
    [5.8] 
and substituting into equation [5.6] gives 
√r*2 − (r cos θ2)2 = X  c√
(r*)2−(r cos θ2)2
(n1r*/n2)2−r*2+(r cos θ2)2
 r sin 2 b tan 1 [5.9] 
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Since 1 and 2 are known and constant, this equation allows calculation of r* for any r. 
It is also necessary to take into account the angle between the outgoing beam 
direction and the normal to the detector, since this determines the solid angle subtended 
by the detector. As shown in Figure 5.1, this angle is equal to 1*, and n1 sin 1* = n2 sin 
2*, with sin 2* given by a previous equation. The scattering event considered explicitly 
gives a spherical wave, so intensity decreases as (r*)until it exits the condensed phase.  
Assuming the wave is still diverging, r* must be replaced by r* + d*, where d* obeys   
(d*)2 = c2 + (Xxe)2     [5.10] 
Here, d* is the distance between the exit point and the detector. 
The total intensity at the detector is proportional to the integral over r of er (for 
attenuation of incident beam intensity) multiplied by er* (for attenuation of scattered 
intensity), by the elastic or inelastic scattering coefficient, by cos 1*, and by the ratio of 
the detector area to the area of the sphere of radius r*+d*. This gives 
I* = I [a+(1)b] cos 1* ∫ dr
𝑞
0
e−(r+r*)
A
4π(r*+d*)2
  [5.11] 
for elastic scattering, where A is the area of the detector and I is the original intensity.  
Here, q = h sec 2. For inelastic scattering, a and b are replaced by a and b. In the 
integral, the angles 1* and 2*, like r*, are functions of r.   
Equation [5.11] shows the dependence of detected intensity on , the volume 
fraction of phase a (quartz) in the condensed phase. There is an explicit dependence, as 
well as an implicit one, through . The attenuation coefficient  is given by Equation 
[5.1], which suggests it is only weakly dependent on . If   constant, I* will clearly be 
a linear function of  (volume fraction of quartz). In addition, the scattering from the 
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aqueous phase comes only from the dissolved porphyrin, so that b and b are 
proportional to the porphyrin concentration cp. This means that the scattered radiation I* 
is also a linear function of cp. The dependence of  on  and cp is negligible for optically 
thin or dilute systems. Most important, it will be shown that experimental EE and IE are 
indeed linear functions of  and cp for our system. 
 
5.3.   Experimental 
 For these trials we acquired the needed materials. Meso-tetra (4-sulfonatophenyl) 
porphine dihydrochloride (porphyrin) was purchased from Frontier Scientific, both 
cesium chloride and sodium azide from Sigma Aldrich, and 8 µm diameter quartz 
microspheres (SiO2MS-1.8 8um) from Cospheric. All reagents were used without further 
purification. All solutions were filtered before use with Whatman 0.2 µm Inorganic 
Membrane Filters (6809-2022). 
 Then we prepared the samples. An aqueous CsCl fluid phase was prepared in DI 
water having a density of 1.42 g/mL after filtration. A stock porphyrin solution was 
prepared by adding excess porphyrin to DI water then was filtered to give a 513 µM 
solution which was measured by absorbance. A stock solution of sodium azide was 
prepared at 500 µM in filtered DI water. Samples were prepared by suspending quartz 
spheres in the filtered CsCl solution. The highest concentration of quartz was prepared at 
0.000833 v/v by a measurement of the mass and converting to volume by the given 
density. Each subsequent sample was prepared by a two-fold serial dilution of the 
previous sample using the stock CsCl solution to dilute. The blank sample at 0.0 v/v 
consisted of the filtered CsCl solution in the absence of quart. The training set had six 
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samples each starting with zero porphyrin. After the initial 30 second spectrum at zero 
porphyrin, 10 µL of the stock porphyrin was added and stirred in the cuvette with a rinsed 
and dry thin metal spatula before acquiring a subsequent spectrum. This was repeated 
until 50 µL of porphyrin had been added for each sample. Settling curves were conducted 
on freshly prepared samples with 0.000833 v/v quartz and 8.55 µM porphyrin. 
 Absorption spectra were obtained using a Cary 50 UV/Vis spectrophotometer. 
Temperature data was collected on a Vernier LabQuest 2 Logger Pro with a temperature 
sensor attachment. NIR emission spectra were obtained using a homemade apparatus 
with a continuous wave external cavity laser operating at 785 nm (Process Instruments, 
Salt Lake, UT). The laser delivers a maximum of 450 mW at the sample in a 1.5 cm-1 
spectral bandwidth within a multimode spatial distribution. By direct observation, the 
depth of focus was ~7 mm. From the top of the cuvette, its center was located ~2 ± 1 cm 
below the surface of the liquid or equivalently ~1 ± 1 cm from the bottom of the cuvette. 
The data was collected on a -55 °C cooled Andor CCD camera where each spectrum had 
an acquisition time of 30 seconds with 150 accumulations of 200 msec frames. The 
experimental geometry is shown in Figure 5.2. 
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Figure 5.2. Experimental geometry of the 785 nm homemade apparatus. 
 
5.4.   Training Set Data 
The validity of the algorithm is dependent on the linear dependence of both EE 
and IE on quartz volume fraction and porphyrin concentration. To demonstrate this and 
calibrate the model to a specific system, a “training set” with six quartz volume fractions 
and six porphyrin concentrations, including all combinations, was measured.  Results are 
shown in Figure 5.3. The dark current was measured 6 times and the average EE and IE 
were 2.96x106±409 and 1.44x108±2.35x104 respectively where the uncertainties represent 
1 standard deviation. These uncertainties are about 0.016 % standard error or less and are 
much smaller than the spread in data so we know that the main sources of noise and error 
for IE and EE are other factors. Since the noise in the dark current, assuming it is all shot 
noise, amounts to only ≈0.06 % of the “dark” EE (1719 counts) or 0.008% of the “dark” 
IE (11996 counts) and the observed variability in the measured training set is much 
greater, the largest source of noise and error is the variable placement of the cuvette 
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(which changes reflections from the bottom and sides of the cuvette) and the 
reproducibility in stirring. 
It may be noted that EE and IE signals are observed for plain aqueous CsCl in the 
cuvette in the absence of quartz or porphyrin. As in all such systems, there is a volume 
determined by the excitation and collection optics and the etendue of the spectrograph 
from which light can potentially enter the spectrograph and be accurately focused onto 
the detector in the output image plane. The presence of apertures and distance ensures 
that only a very small amount of light from within the cuvette can propagate through the 
spectrograph to the detector(s). Direct observation shows that in the system used to 
collect the data, incident light is loosely focused in the space several millimeters below 
the surface of the sample solution and several millimeters from the bottom of the cuvette. 
Although most of the light we analyze comes from that volume in the cuvette, 
there is also a reproducible background EE and IE because some of the incident light 
propagates to the bottom of the solution, to an extent depending on the quartz and 
porphyrin volume fraction and concentration. Therefore, some EE and IE is produced 
when the light contacts the bottom of the cuvette. That light must propagate back through 
the cuvette and the porphyrin and quartz spheres as well as the optical system outside of 
the cuvette to be ultimately collected. This is a well-defined background emission that is 
well managed by our procedure as indicated by the overall good statistics and internal 
consistency of the training set.  
Note that all in vivo systems possess a third phase—static tissue—that produces a 
background and all in vitro experiments must somehow contain the system under study 
and the container almost always produces some kind of background EE and IE, in 
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addition to the EE and IE from contained material. This is the signal that is observed for 
plain aqueous CsCl in the cuvette with no quartz orporphyrin. However, the main 
limitations on accuracy and precision in applying this algorithm in vivo to date are so-
called “human factors”.14 
After examining a larger range, the upper limit of the quartz volume fraction was 
chosen to be the edge of linearity to display the model’s range of applicability. Note that 
the contribution of porphyrin to EE is negligible compared to that of the quartz, so that 
simple linear least squares regression of the quartz volume fraction on EE alone was not 
statistically significantly different from bilinear regression that includes IE. The situation 
is similar to the in vivo Rayleigh scattering coefficient of plasma36 being smaller than that 
of RBC’s, one way in which the present system resembles the in vivo situation. 
The plots are linear in all cases.  For the 24 plots of Figure 5.3, the values of the 
dimensionless parameter X, equal to the slope multiplied by the maximum x-value and 
divided by the average y-value, and the values of the coefficients of determination R2 are 
given in Table 5.1. The plots are identified by the panel of Figure 4 (A, B, C, or D) and 
numbered from bottom to top (1 to 6).  The values of R2 are 0.98 or greater for all the 
plots of A, B, and D. For the plots of C, R2 is not a useful measure of linearity because 
the best-fit lines are horizontal. More relevant are the root-mean-square deviation from 
the mean divided by the mean, or X, the ratio of the largest deviation from the mean to 
the mean. A small value of X indicates a plot which is essentially horizontal. Calculated 
values of X are, for plots C1 through C6: 2.8%, 1.0%, 0.2%, 1.7%, 2.0%, 2.0%. Only for 
C1 is X greater than 2%. The problem here is the 2nd point. When it is removed, X drops 
to 0.7%. 
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Table 5.1. Values of X (maximum excursion from mean divided by mean value) and R2 
(coefficient of determination) for the plots of Figure 6.3. 
Plot # X parameter R2 Plot # X parameter R2 
A1 0.818 0.996 B1 2.169 0.998 
A2 0.875 0.996 B2 1.767 0.994 
A3 0.845 0.996 B3 1.526 0.987 
A4 0.836 0.998 B4 1.332 0.992 
A5 0.832 0.996 B5 1.227 0.988 
A6 0.857 0.997 B6 1.139 0.986 
C1 0.0284 0.131 D1 1.278 0.995 
C2 0.0104 0.227 D2 1.057 0.988 
C3 0.0020 0.020 D3 0.937 0.983 
C4 0.0172 0.850 D4 0.843 0.988 
C5 0.0199 0.489 D5 0.619 0.984 
C6 0.0197 0.499 D6 0.424 0.986 
 
 
Figure 5.3. Training set data arranged to show trends in both EE and IE for each species. 
The EE (-13 to 44 cm-1) and IE (900 to 1900 cm-1) are calculated after a dark current 
subtraction of each spectrum. The EE (a) and IE (b) of changing quartz have lines at the 
following porphyrin concentrations: 0.0 µM (■), 1.7 µM (●), 3.4 µM (▲), 5.1 µM (▼), 
6.8 µM (♦), and 8.5 µM (◄). The EE (c) and IE (d) of changing porphyrin have lines at 
the following quartz volume fractions (1x10-5): 0.0 v/v (■), 5.2 v/v (●), 10.4 v/v (▲), 
20.8 v/v (▼), 41.7 v/v (♦), and 83.3 v/v (◄). 
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The horizontality of the plots of Figure 5.3A shows that the porphyrin does not 
contribute to the elastic scattering intensity EE. This is also the reason that the plots of 
Figure 5.3A fall on top of each other. The rejected data point (0.0 v/v quartz and 1.7 µM 
porphyrin), which deviates from linearity in Figures 5.3A and 5.3C, could be due to 
various experimental errors (e.g. a dust particle or back reflection). It serves as an 
example that the EE and IE can in fact be counted as independent measurements, a 
requirement for applicability of the algorithm. Although the EE from this spectrum could 
be rejected by the Q-Test at a 99% confidence,73 the IE data point cannot be considered 
an extraneous value by the same test. Only the EE data point was excluded from 
subsequent analyses. 
 
5.5.   Applying the Algorithm 
Since both EE and IE are bilinear functions of  (quartz volume fraction) and cp 
(porphyrin concentration),  and cP are linear functions of EE and IE so we can write 
equations [5.12] and [5.13]. 
cp =a+ b(EE) + c(IE)    [5.12] 
= d+ e(EE) + f(IE)    [5.13] 
The parameters a-f were obtained from a bilinear fit on the training set in Figure 5.3.  The 
values were: a = (1.241010)M, b = 101014)M, c = 
(2.101013)M, d = 7.28104±1.51105, e = 1010, f = 
1010. Note that quartz volume fraction and numbers of counts are 
unitless.  
Using these parameters in the algorithm of [5.12] and [5.13] to “predict” the 
quartz volume fraction and porphyrin concentration from the values of EE and IE of the 
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training set, we obtained the results shown in Figure 5.4. Calculated values are on the y-
axis, actual or “expected” values on the x-axis. For quartz, the slope is unity 
(corresponding to perfect prediction) to within 0.4% and the intercept is zero to well 
within the standard error; R2 = 0.996. For the porphyrin R2 is considerably lower (0.94) 
but the slope is still unity and the intercept is zero, both within their respective standard 
errors. 
The standard error of the estimate is calculated as 
   𝜎𝑒𝑠𝑡 = √
∑(𝑌𝑒𝑠𝑡−𝑌𝑎𝑐𝑡)2
𝑁
   [5.14] 
where N is the number of points (35 in the present case), and Yest is the value of  or cp 
calculated from the linear equations, and Yact is the actual value of  or cp. The value of 
est is 1.85x10for the volume fraction of quartz, and 7.02x10 for the porphyrin 
concentration. None of the points in Figure 6.4 deviates from the trend line by more than 
two standard deviations. 
 
Figure 5.4. The algorithm was applied to the training set data to calculate quartz and 
porphyrin. (a) The expected volume fraction of quartz is plotted against the quartz 
volume fraction calculated from the bilinear fit. (b) The expected concentration of 
porphyrin is plotted against the concentration of porphyrin calculated from the bilinear 
fit. 
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Despite the fit to the porphyrin displaying satisfactory linear correlation, there 
appears to be systematic error: in other words, curvature. Graphing the porphyrin and 
quartz residuals against each other, a linear fit produces an R2 of about 0.1, an estimate of 
the covariance60 between the two predicted values. This suggests that about 10% of the 
prediction errors in quartz and porphyrin are correlated with each other in a manner not 
accounted for by the purely linear model and including a cross term EE*IE in the fitting 
function did improve R2 significantly. Correlated errors could result from laser power 
fluctuations or cuvette placement as just two examples and so a more extensive 
discussion is beyond the scope of this paper. We also introduced quadratic terms in EE 
and IE so that 
=a+ b(EE) + c(IE) + d(EE2)  [5.15] 
      cp=e+ f(EE) + g(IE)+ h(EE
2)  [5.16] 
The values found for the parameters are as follows: a = 10105, b 
= 1010, c = 1010, d = 1010, e = 
(2.2110106)M, f = 1012±1.581013)M, g = (3.0310-12±9.6710-
14)M, h = (1.101021)M.   
Using only the term in EE2 in addition to the linear terms, the results of Figure 5.5 
are obtained. There is a significant improvement in R2 for the porphyrin, Figure 5.5B. 
The intercept is closer to zero and the slope closer to unity, than each was in the fits of 
Figure 5.4, which did not include the quadratic term. 
We also analyzed, using our model, the data obtained as the quartz spheres settled 
through and out of the observation volume of the laser. The density of the CsCl solution 
is such that, in the 30 seconds that each individual sample is analyzed for the training set, 
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there is no significant change in the measured signals. Direct visual observation shows 
that about 22 minutes is required for the quartz to settle to the bottom of the cuvette as the 
fluid phase above becomes progressively clearer.   
 
 
 
Figure 5.5. The algorithm with an added EE quadratic term was applied to the training 
set data to calculate quartz and porphyrin. (a) The volume fraction of quartz calculated 
from the fit is plotted against the actual or expected volume fraction. (b) The 
concentration of porphyrin calculated from the fit is plotted against the actual or expected 
concentration of porphyrin. The statistics of each fit line demonstrates the accuracy of the 
fit. 
 
 
5.6.   Observation of Quartz Settling 
A sample of the measured EE and IE during settling is shown in Figure 5.6. For 
fresh samples, both EE and IE curves are very reproducible. However, if a sample is 
stirred and analyzed again as in Figure 5.6B, the EE repeats the first run, starting at the 
level at the beginning of the first run, while the IE reverts to the level at the end of the 
first run, which is lower than the beginning level. It is well known16,17 that aqueous 
porphyrin emission is bleached when irradiated with NIR in the presence of oxygen, so 
that the initial IE in the second run is close to the final IE in the first run is not surprising. 
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This bleaching is analogous to the well-known bleaching of autofluorescence17 that 
occurs when tissue is irradiated with NIR in vivo. 
 
Figure 5.6. Calculated EE (a) and IE (b) of a fresh sample (83.3x10-5 v/v quartz and 8.55 
µM porphyrin) where squares represent the first run and circles the second run, begun 
after the solution was stirred again. Each data point is calculated from a 30 second 
spectrum averaged over 150 accumulations. 
 
The EE is due almost exclusively to the quartz (see Figure 5.3C), whereas the IE 
has contributions for both quartz and porphyrin. The porphyrin makes a much greater 
contribution to the IE for the concentrations we use. The ratio of the average slopes of the 
lines in the training set figures 5.3B and 5.3D shows the comparison. The ratio is ≈49:1 
indicating that an increase of 0.02 ppm in quartz volume fraction produces an IE increase 
equivalent to an increase in porphyrin concentration of 1 M.   
For the initial ~7 minutes, the system is almost homogeneous and the training set 
algorithm allows calculation of  and cp. When settling becomes important and the 
system becomes spatially inhomogeneous, the algorithm cannot be used, although the EE 
and IE can still be used to monitor the evolution of the system. Settling depletes the 
quartz, starting at the top of the container (z = 0). Density profiles calculated for a related 
system74 are presented in Figure 5.7. 
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Figure 5.7. Characteristics of settling. (a) Density profiles calculated for a related 
system72 at times t0 = 10, t1 =30, t2 = 50, t3 = 70, t4 = 90 and t5 =110 minutes. The profiles 
are almost vertical, indicating a sharp boundary between a quartz suspension and a 
quartz-free solution. (b) Approximate two-layer description of system when 
sedimentation front has moved down almost to the bottom of the cuvette (z = -h). 
 
Note that the volume fraction of solution is essentially the same everywhere. It 
varies from 1 to 1 but, since the volume fraction of quartz  is less than 10-3, the 
change is negligible. Thus the contribution of the porphyrin to EE is given by equation 
[5.11] above, with  = 0 at all times, and the contribution to IE is given by [5.11] with b 
replaced by b. Since b and b are proportional to the porphyrin concentration, we must 
take into account the degradation of the porphyrin. We get an estimate of the degradation 
rate from the measured inelastic scattering intensities, since they are dominated by the 
porphyrin. When cp = 0 and = 8.3310, IE = 5.84210, which represents the 
contributions of the quartz and the cuvette. The IE values for the first 6.5 minutes of the 
settling experiment are reduced by this amount, and the difference, representing the 
porphyrin, is fitted to an exponential eCt. The best-fit value of the degradation rate 
constant C is 0.0655 min-1. 
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When the sedimentation front has moved far down (see Figure 5.7B), there is 
essentially no quartz for z >k (where hk is small). The contribution of the quartz to the 
elastic scattering is given by a modification of equation [5.11]: 
Iquartz* = I cos 1* ∫ dr φ(z)𝛽a
𝑞
𝑝
e−(r+r*)
A
4π(r*+d*)2
  [5.17] 
Now  is a function of z, and the integral extends from p = k sec 2 to q = h sec 
2. For the inelastic scattering,  is replaced by . If hk is small, the integrand in [5.17], 
except for (z), is roughly independent of r. This makes the integral approximately 
proportional to T = ∫ dr φ(z)
𝑞
𝑝
. Since all of the quartz is in the lower layer, h < z <k, T 
represents the total quartz in the system, which is constant. This means that Iquartz* 
approaches a constant for large time. 
The contribution of the quartz to the measured scattering may be obtained by 
subtracting the porphyrin and cuvette contributions from the measured scattering. From 
the linear fits of Figure 5.3 data for zero quartz and 3.2910-6M cp 8.2110-6M we 
obtain EE = 1.692107 + 1.1871010cP, IE = 5.923105 + 3.2591011 cp. Combining 
these with the effective porphyrin concentration as a function of time, 8.55100.0655t, we 
obtain the porphyrin + cuvette contributions to the IE and the EE. Plotted against time, 
the curves are roughly parallel, as expected. 
 
5.7.   Porphyrin Photodegredation 
Some experiments were conducted to more fully appreciate the effect of the 
porphyrin photochemistry on the training set and other measurements. Figure 5.8 displays 
the EE and IE for two identical solutions containing both porphyrin and quartz, one with 
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dissolved oxygen in equilibrium with the local atmosphere and the other with the oxygen 
reduced by pre-bubbling argon through the solution. The EE is essentially unaffected but 
the IE is much smaller when more oxygen is present, indicating that most if not all of the 
reduction in IE is due to porphyrin photochemistry involving oxygen.  
 
Figure 5.8. EE (a) and IE (b) of two identical fresh samples (83.3x10-5 v/v quartz and 
8.55 µM porphyrin), one bubbled with argon and the other with oxygen. The squares 
represent the solution bubbled with argon and circles the solution bubbled with oxygen. 
 
Soret band (411 nm) absorption measurements were made on the fluid phase 
before and after irradiation (with the quartz spheres filtered out before each 
measurement), as shown in Figure 5.9. These spectra demonstrate that under identical 
conditions, the effective porphyrin concentration is decreased by >80% during a 22 
minute settling period. Assuming exponential decay, cp = c0 e
Ct, this gives  
   C = 
−ln (0.2)
22 𝑚𝑖𝑛
 = 0.073 min-1   [5.18] 
which agrees well with the estimate above, from the IE during the first 6.5 min of 
settling, of 0.066 min-1.  
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Figure 5.9. Soret band (411 nm) absorption of two identical fresh samples (83.3x10-5 v/v 
quartz and 8.55 µM porphyrin). The solid line is the measured absorption of the filtered 
solution without exposure to the NIR laser while the dashed line is the solution filtered 
after 22 minutes of irradiation. 
 
Another estimate of C may be obtained in the context of the two-layer model 
introduced above. At later times, the contribution of porphyrin to the IE is mostly from 
the upper layer, and would be constant in time were it not for the decay of porphyrin. The 
IE should then behave like I(t) = A + B eCt with A representing the contribution of the 
lower layer and the container; it is expected that A is smaller than B. Fitting the IE for t  
14 minutes to I(t) yields A = 2.6106, B = 1.05107, C = 0.085 min-1. Using a later start 
time gives a lower value of C. 
We also performed experiments involving azide, a known physical quencher of 
singlet oxygen,75 in the form of added sodium azide. In these experiments, EE and IE 
were measured while the system was allowed to settle for 22 minutes (first run), the 
system was stirred and the measurement repeated for 22 minutes (second run), and 
stirring and measurement were repeated once more (third run). The presence of azide in 
the absence of porphyrin has no significant effect on either IE or EE. However, when 
both porphyrin and oxygen are present, azide does have an effect, as shown in Figure 
5.10. 
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Figure 5.10. EE (a) and IE (b) of a fresh sample (83.3x10-5 v/v quartz, 85.5 µM 
porphyrin, and 85.5 µM azide) where squares represent the first run, circles the second, 
and triangles the third with stirring between successive runs. 
 
The results in Figure 5.10 are for a concentration of azide equal to the porphyrin 
concentration compared to Figure 5.11 where the azide concentration is half that of the 
porphyrin. The settling of the quartz, as indicated by the EE, is accompanied by a 
decrease in the IE, which continues in successive runs. However, this decrease is less 
than in the absence of azide. With higher azide concentration, the decrease is even 
smaller. The known quenching of excited porphyrin by azide76 in competition with 
singlet oxygen production at higher azide concentration accounts for these observations. 
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Figure 5.11. EE (a) and IE (b) of a fresh sample (83.3x10-5 v/v quartz, 85.5 µM 
porphyrin, and 42.3 µM azide) where black squares represent the first run, red circles the 
second, and blue triangles the third with stirring between successive runs. 
 
When azide is present with porphyrin, the EE during the course of the settling has 
a more drawn-out appearance, with neither the quartz volume fraction nor the porphyrin 
concentration becoming as low at 22 minutes. In addition, the first settling profile in the 
sequence has a more distinct fall off than the later ones and the EE is actually greater for 
the later runs than the first run. By “distinct” we mean that the EE has a discernable 
second stage starting at about 10-15 minutes whereas the fall-off for successive runs is 
smoother with no second stage. All of these observations are consistent with the idea that 
the quartz settling is disturbed by laser-induced temperature gradients, such as heating. 
Figure 5.12 shows the results of measurement, using a thermocouple, of the 
temperature of the solution during settling and irradiation, using fresh solutions similar to 
those of Figures 5.7, 5.10, and 5.11. There is a sharp temperature rise if both porphyrin 
and azide are present, a relatively weak temperature rise if only porphyrin is present and a 
very weak one if only azide is present. The temperature rise starts immediately when the 
irradiation begins and immediately reverses when the laser light is removed. Only when 
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light, porphyrin, oxygen, and azide are all present is the temporal profile of the quartz 
settling affected and a distinct temperature rise observed. 
 
Figure 5.12. (a) Temperature change with 785 nm laser irradiation. Red represents a 
fresh sample with 8.83x10-5v/v quartz and 85.5 µM of both quartz and azide, green with 
only quartz and porphyrin, and black with only quartz and azide. (b) The same increasing 
temperature data is shown from A along with the decline in temperature after the laser 
was turned off. 
 
5.8.   Summary 
The above measurements are for a two-phase system, with one phase being a 
solution of variable concentration that does not scatter elastically and the other a strongly 
elastic scattering pure solid phase. The results show that a simple linear algorithm can be 
calibrated to allow simultaneous determination of concentration and phase volume 
fractions from measurements at a single excitation wavelength, with the remitted light 
separated into two components. It is thus possible to obtain quantitative information from 
dynamically turbid solutions if the effect of the turbidity is accounted for by 
simultaneously measuring the EE in addition to the IE. Usually, the IE is the only signal 
available. 
One reason for this demonstration was to establish the validity of a linear 
algorithm for a simple system having some of the features of the kind of system we 
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ultimately seek to describe. Our goals were first to gauge the performance of the 
algorithm under nearly ideal conditions and then to assess the interpretability of the 
response of the algorithm to perturbations in the system.  
The results show that linear relations exist between the IE and the EE, and the 
quartz (elastic scatterer) volume fraction and fluorophore or Raman scatterer 
concentration. The EE is linear in the quartz volume fraction  and statistically 
independent of the porphyrin concentration cP. When linear relations were used to 
calculate  and cP from measured EE and IE, they accounted for over 94% of the 
variation in  and cP. Addition of a quadratic term in elastic scatterer volume fraction to 
the linear treatment improved the correlation with the measured porphyrin values by 3% 
which was statistically significant77 at better than 99% confidence, but did not make a 
statistically significant change in the ability to predict quartz volume fraction. Successive 
applications of the F test showed that each quadratic term (EE2, IE2, IE*EE) made a 
statistically significant improvement in the predictive calibration for porphyrin. 
Nevertheless the linear terms and EE2 alone contain almost all of the dependence on both 
porphyrin and quartz of EE and IE. The calibration lines for calculated porphyrin and 
quartz versus actual porphyrin and quartz had slopes of 1.0 and intercepts of 0.0 within 
experimental error.  
The shot noise of the raw EE and IE or the dark current (from integrating the 
same pixel ranges for EE and IE) was not enough to account for the spread in the raw 
data in the training set. We conclude that the detection limits in this system are 
determined by reproducibility in sample placement and stirring. Note that in an in vivo 
setting, placement error would be quite different since the “cuvette” is the surrounding 
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static tissue. There is no stirring but human factors could induce motion and other 
defects. 
When any in vivo probed region is irradiated17 the autofluorescence bleaches (or 
decreases), reaching a steady state value (material is supplied by, for example, blood 
flow) in seconds to several minutes, depending on the tissue, the applied power, and the 
excitation and emission wavelengths. Our apparatus15 monitors this decay and calculates 
reference EE0 and IE0 when the IE has reached steady state. The present work shows that 
the rate constant for bleaching can be extracted from the data, so that earlier time points 
can be used. Since unbleached tissue produces much more IE, movement of the point at 
which the incident light contacts the tissue (for example, due to the human patient being 
noncompliant with instructions) causes a temporal spike in the “apparent” plasma volume 
and Hematocrit.   
 The best measure of the precision in the apparatus for the in vitro system is the 
spread in the values predicted for the training set data. Using the purely linear algorithm, 
the standard deviation for predicted quartz volume fraction is 19 ppm and 0.72 M for 
predicted porphyrin concentration. These values are ≈2% and ≈10% of the range over 
which the algorithm was calibrated, and were obtained without optimization of apparatus 
or procedure, and with a single light source in the NIR for which there is only very weak 
absorption by porphyrin. The background of reflections involving the cuvette, and 
fluorescence from the cuvette made reproducible cuvette placement essential to obtaining 
precise results. 
For the ranges of  and cP studied, the EE was independent of porphyrin 
concentration and linear in quartz v/v, and the IE linear in both. For larger ranges, the IE 
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fit was improved by adding small quadratic terms in quartz and porphyrin and a cross 
term, to the linear terms in quartz and porphyrin. The linear algorithm underestimates the 
porphyrin for larger quartz volume fractions because the raw IE becomes concave down 
with quartz volume fraction beyond the linear range. Sometimes, the turbidity can be 
reduced to the level required for applicability of the linear algorithm, such as a simple 
dilution of a sample might be adequate to reduce native turbidity to a level that can be 
calibrated for in advance.   
It is not surprising that this algorithm can be applied successfully to the 
volumetric analysis since the use of empirically calibrated turbidity or nephelometry 
measurements for endpoint detection in precipitation reactions is well known.78 On the 
other hand, an absorption loss due to uncontrolled dissolved materials in the fluid phase 
might interfere with that approach. Since it allows analysis at concentrations well below 
the detection limit of the same analyte by absorption76, use of fluorescence by itself in 
quantitative analysis of a fluid phase is common. However, sample preparation, e.g. 
filtering may be required for reliable, precise and accurate results. In certain situations, 
where simultaneous chemical and volumetric analysis of a turbid fluid phase is required, 
the approach we describe can be executed conveniently using a single laser source, 
simple spectral filters, single channel detectors and possibly in situ or with little or no 
sample preparation. The simultaneous determination of an absorber/scattering system like 
this could not be accomplished by absorption/optical density measurements using a 
single-color light source. 
We studied this system because of analogies to our main interest, in vivo 
applications. When applied to blood measurements, the algorithm of Equations [2.4] and 
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[2.5] is used in the form of Equations [2.6] and [2.7], which involve reference values for 
the EE and IE since clinical interests focus attention on changes from the reference state 
of homeostasis. The anatomy of most tissues is very well defined and the principle of 
steady states or homeostasis43 ensures that in general changes in physiological parameters 
that determine the optical properties of a tissue like skin occur slowly. Thus, if the 
volume fraction and chemistry of tissue are constant or nearly so, the algorithm will 
reveal changes in concentrations of materials in the only fluid changing to any 
appreciable extent: the blood.  
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6. Blood Samples Investigated in vitro 
 
6.1.   Interest in Study 
 The in vitro study described in Chapter 5 provided a model system that is 
analogous to the blood in that the quartz spheres modeled the red blood cells and the 
porphyrin modeled the plasma. RBC’s form a circle in the x-y plane but have a biconcave 
shape in the z-axis rather than forming a sphere.79 They also contain a solution inside 
allowing them to deform which changes the viscosity of the blood.80 The quartz sphere is 
sufficient for modeling the RBC’s in the context of the algorithm but fails to fully model 
all of the properties of the RBC’s. The algorithm uses the measure of EE, a result of 
physical scattering, to calculate RBC concentration but the RBC’s do not have a spherical 
shape as the quartz spheres do resulting in slightly different scattering properties. Using a 
solubilized porphyrin to model the plasma fits as there is a natural level of porphyrin in 
the plasma and the porphyrin gives a fluorescence signal, as does the plasma.81 
 The in vitro model provides support that the algorithm works well in a controlled 
and defined system. The in vivo environment is very well defined physically and is highly 
regulated internally to achieve homeostasis supporting the evidence that the algorithm is 
measuring changes in the blood noninvasively based on the data and explanations from 
Chapters 3-5. To further give evidence to the validity of the algorithms calculations of 
PV and Hct, an in vitro study with blood should be investigated. Two of the requirements 
for the algorithm are that the majority of collected light must be in the single scattering 
range and that the measured values are within a linear range. Figure 2.1 demonstrated 
how the in vivo probe was designed to collect mostly singly scattered light and section 
5.2 describes the prevalence of singly scattered light from the cuvette model. When 
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measured in vivo, the blood cannot be intentionally changed to make a calibration curve, 
therefore an in vitro model of blood should be able to demonstrate physiologically 
relevant linear ranges for volume fractions of PV and RBC’s.   
 Another important aspect of attempting to obtain justification for the in vivo use 
of the algorithm from an in vitro model system involving blood itself has to do with the 
unusual optical properties of RBC’s. It is well known that the elastic scattering 
coefficient depends on RBC orientation, deformation, and axial migration within 
whatever vessel contains the sample. Such changes of RBC orientation are known to 
occur as a function of flow and shear rate in vivo and also in in vitro flow systems. Being 
aware of this complexity from the outset we adjust our expectations as to how well we 
can meet the conditions for the applicability of the model and the associated algorithm in 
any static RBC containing system. 
 
6.2.   Experimental 
All procedures performed using animals were conducted under IACUC approval 
at Syracuse University. Whole blood was drawn from rats at the end of their lifespan to 
use for in vitro experiments. Blood was also drawn from Dr. Chaiken and me at a nearby 
hospital by a registered nurse. The 830 nm spectroscopic measurements employ the same 
instrument used in Chapter 3 except with probes designed for liquid samples. Each 
spectrum had an acquisition time of 200 seconds with 10,000 accumulations of 20 msec 
frames. The 785 nm spectroscopic measurements were obtained on the same instrument 
described in Chapter 5. 
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The materials used include Phosphate Buffered Saline 10X, purchased from Santa 
Cruz. The PBS was filtered before use with Whatman 0.2 µm Inorganic Membrane 
Filters (6809-2022). Whole blood was collected in BD VacutainerTM Plastic Blood 
Collection Tubes with K2EDTA 5.4 mg (Fisher Scientific). 
The sample preparation used the 10X PBS which was diluted to 1X with filtered 
DI H2O for use in experiments. The whole blood was separated and cleaned before use as 
follows. The fresh blood was centrifuged for six minutes at 6.0 g to separate the plasma 
from the RBC’s. The plasma was decanted from the top of the RBC’s and placed in a 
separate container. To wash the RBC’s, 1 mL of 1X PBS was added and gently mixed by 
inverting the sample tube several times. The RBC’s were then centrifuged as before. The 
top layer of PBS and white blood cells were decanted and disposed.  The RBC’s were 
then washed a second time. Any dilutions of plasma or RBC’s were made into the 1X 
PBS solution. 
 
6.3.   Experiments at 785 nm 
 The instrument used in Chapter 5 was dedicated to in vitro experiments making it 
the instrument of preference for the quartz and porphyrin model. Since the model system 
worked so well on the 785 nm instrument, the blood was also analyzed on the same 
system for comparison and reproducibility. Direct comparisons between an in vitro 
experiment at 785 nm and the in vivo experiments at 830 nm will not be possible 
however, demonstration of linearity in both PV and Hct is for EE and IE would further 
give credence to the algorithm. 
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 Both the plasma and the RBC’s cause some scattering in solution though RBC’s 
cause much more scattering. The RBC’s are particles which scatter and the plasma 
contains proteins which can cause scattering. At the upper limit of the single scattering 
range, an increase in volume fraction will no longer produce a linear increase in signal. 
The first step is to find the point at which the signal starts to “turn over” due to multiple 
scattering. Figure 6.1 gives a visual of the increase in scattering from plasma and RBC’s.  
 
Figure 6.1. Images of 785 nm irradiated diluted plasma (left), diluted RBC’s (middle), 
and more concentrated RBC’s (right). 
  
The plasma contains macromolecules and platelets that cause some scattering but 
mostly fluorescence while the RBC’s cause a large amount of both scattering and 
fluorescence. Images from Figure 6.1 were taken during the experiments in Figure 6.2 to 
find the linear ranges of both plasma and RBC’s for measured EE and IE. The middle and 
right images from Figure 6.1 demonstrate how an increase in RBC volume fraction 
decreases the penetration of the laser into the solution and increases the probability of 
multiply scattered photons. Note that signals produced by the cuvette walls (including the 
sides and bottom respectively) also can be important at both high and very low RBC 
volume fractions. A different penetration effect occurs when EE and IE are collected at 
90 degrees to the incident light, as will be described in Chapter 6.4, compared to when 
light is collected in a purely backscattered configuration. 
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 Qualitatively, as with all other systems checked, starting at zero concentrations, 
both the EE and IE increase linearly with 1) increasing concentration of scattering center 
e.g. RBC’s and 2) increasing concentration of molecules such as proteins respectively. At 
some point the increase stops and the EE and IE actually decrease with added scattering 
center and molecular concentrations causing the curves to “turn over”. 
 
Figure 6.2. The EE and IE of both RBC and plasma volume fractions were analyzed over 
several days to find the linear ranges. Each data point is dark current subtracted. 
 
Data in Figure 6.2 from 8/16 demonstrated clearly that the RBC’s would turn over 
in signal for both EE and IE at around 0.001 v/v which equates to 3 µL of pure RBC’s in 
a 3 mL solution. The ranges of plasma proved to be linear in the ranges tested and while 
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the turning point was not observed, the abundance of collected blood dictated the volume 
fractions used. With linear ranges established, a training set was designed with six 
volume fractions of RBC’s and six volume fractions of plasma and all of the 
combinations between, shown in Figure 6.3.  
 
Figure 6.3. Training set data arranged to show trends in both EE and IE for each species. 
The EE (-13 to 44 cm-1) and IE (900 to 1900 cm-1) are calculated after a dark current 
subtraction of each spectrum. The EE (a) and IE (b) of RBC’s have lines at the following 
plasma volume fractions: 0.0 (■), 0.02 (●), 0.04 (▲), 0.06 (▼), 0.08 (♦), 0.1 v/v (◄). 
The EE (c) and IE (d) of changing plasma lines at the following RBC volume fractions 
(1.0E-4): 0.0 (■), 1.33 (●), 2.67 (▲), 4.0 (▼), 5.33 (♦), and 6.67 v/v (◄). 
  
The trends for the training set were fairly linear with the IE more stable than the 
EE because incident light impinging on the cuvette surfaces produces much more EE and 
IE and there is no specular reflection of IE. Changes in counts for EE are on the same 
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scale for both RBC’s and plasma but the IE change for RBC’s is much stronger than for 
the plasma. To test if the linearity is sufficient for the algorithm, a multiple linear 
regression was performed for both changing RBC’s and plasma to give the parameters a-f 
from Equations 6.1 and 6.2.  
R = a+ b(EE) + c(IE)   [6.1] 
P= d+ e(EE) + f(IE)    [6.2] 
Measured EE and IE values can then be used in these equations to calculate RBC and 
plasma volume fractions in Figure 6.4. A good fit should have a slope near 1.0 and an 
intercept near 0. Slopes of 0.980 and 0.985 and intercepts of 0, both within experimental 
error, demonstrate a good overall fit to the data for both the RBC’s and plasma with the 
algorithm.  
 
Figure 6.4. The algorithm was applied to the training set data to calculate RBC’s and 
plasma. (a) The expected volume fraction of RBC’s is plotted against the RBC volume 
fraction calculated from the bilinear fit. (b) The expected volume fraction of plasma is 
plotted against the volume fraction of plasma calculated from the bilinear fit. 
 
 The purpose of exploring this in vitro experiment of blood was to compare the 
results to the blood measured in vivo. In the volar side of the fingertip, there is a volume 
fraction of RBC’s around 0.003-0.005 which amounts to an estimated Hct of around 0.1 
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with a perfusion of about 3% blood within the probed region.18 Figure 6.3 shows the high 
end of RBC volume fraction to be at 0.00067 amounting to about five times lower than 
the physiological level. Plasma volume fraction at the physiological level would be near 
the bottom of the range in Figure 6.3. It is known that at 785 nm the scattering coefficient 
for RBC’s is greater than at 830 nm where the in vivo measurements are made.36 A repeat 
of the same type of experiments at 830 nm should therefore give a turnover point for 
RBC’s that is nearer the physiological range and should also give a better balance 
between the signals for plasma.  
  
6.4.   Experiments at 830 nm 
 Experiments at 785 nm were convenient due to the function of the instrument as a 
dedicated in vitro system and comparability with the quartz and porphyrin model from 
Chapter 5. Performing the same type of in vitro blood experiment at 830 nm would have 
the extra benefit of comparing more directly with the in vivo measurements. The finger 
probe from the in vivo experiments is attached through a fiber optic as shown in Figure 
3.1. The finger probe is detachable with different probes that can be attached. A probe 
specifically designed for liquid samples was attached for use in the following 
experiments. Keeping as many variables consistent as possible, the liquid probe was 
mounted above the cuvette holder so that the geometry was identical to the 785 nm setup 
from Figure 5.2. Design of the mount allowed the cuvette to be secured into the cuvette 
holder without moving the probe or the holder, keeping the focus in a consistent spot just 
below the surface of the liquid. Linear ranges were found and are shown in Figure 6.5. 
 
106 
 
 
  
Figure 6.5. The EE and IE of both RBC and plasma volume fractions were analyzed to 
find the linear ranges. Each data point is dark current subtracted. 
 
 RBC’s show linearity over the range for EE but turns over in IE after 0.005 
volume fraction which happens to be around the physiological range. Plasma appears to 
show linearity for both EE and IE across the range chosen and probably to higher volume 
fractions. Compared to the 785 nm system, the signal of the RBC’s has greatly decreased 
and evened out the signal balance between the RBC’s and plasma by more than a factor 
of 4. Within the linear ranges established from Figure 6.5, a training set was comprised of 
six volume fractions of each RBC’s and plasma having every combination which is 
shown in Figure 6.6. 
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Figure 6.6. Training set data arranged to show trends in both EE and IE for each species. 
The EE (-13 to 44 cm-1) and IE (900 to 1900 cm-1) are calculated after a dark current 
subtraction of each spectrum. The EE (a) and IE (b) of RBC’s have lines at the following 
plasma volume fractions: 0.0 (■), 0.025 (●), 0.050 (▲), 0.075 (▼), 0.100 (♦), 0.125 v/v 
(◄). The EE (c) and IE (d) of changing plasma lines at the following RBC volume 
fractions: 0.000 (■), 0.001 (●), 0.002 (▲), 0.003 (▼), 0.004 (♦), and 0.005 v/v (◄). 
 
 The EE shows fairly consistent linear trends for both the RBC’s and the plasma. 
The IE however, was very inconsistent in this and other attempts of the same experiment. 
Linear ranges of both RBC’s and plasma independently appeared well behaved in 
linearity but the mixed samples were consistently poor in linearity. It is possible that the 
RBC’s are concentrated enough to cause multiple scattering possibly from the sides of 
the cuvette or that this configuration allows a reflection from the bottom of the cuvette. 
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The camera from Figure 6.1 worked well with images from the 785 nm laser but the 830 
nm laser did not show up by camera or the eye making visual observation of scattering 
difficult. Scattering from the bottom or sides of the cuvette is always a possibility but it is 
more likely to affect the EE rather than the IE. If the turbidity of the sample is too high, 
the laser may not be reaching the focus and there could be multiply scattered photons 
arriving back to the detector. To test the effects of scattering by the sample, the geometry 
of the instrument was changed.  
 Each probe has a port for the laser and a port for the detector connected by fiber 
optics. With two liquid probes, one could be placed in the z-axis and the other in the x-
axis to give a detection at 90 degrees. Two probes were mounted individually and the 
laser input was shifted between the two probes to align the focus of each probe to the 
same point. When the foci of both probes were aligned the laser was placed in the z-axis 
probe and the detector in the x-axis probe to give a standard 90 degree nephelometric 
geometry.   
 Fresh blood was obtained to determine a linear range in the new geometry of the 
probes. After some initial experiments with the blood, it appeared that the signal may not 
be optimized so the system was better aligned for optimized signal. When more blood 
was obtained, more experiments were done to determine the linear ranges, shown in 
Figure 6.7.  
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Figure 6.7. The EE and IE of both RBC and plasma volume fractions were analyzed to 
find the linear ranges. Each data point is dark current subtracted. 
 
 Unlike previous experiments, the signal decreased with increasing either plasma 
or RBC’s. The purpose of arranging the probes in this nephelometric orientation was to 
determine if the laser might be reflecting off the bottom of the cuvette or if the turbidity 
is causing multiply scattered photons. The decreasing of both EE and IE signal in this 
experiment gives evidence to an increase in turbidity causing less photons to arrive at the 
focus of the collection optics. The probe with the detector is aligned so that it will collect 
the majority of signal from the spot where the laser will come to a focus and the signal 
seems to be decreasing with the shape of an exponential decay.  
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6.5.   Summary 
 Noninvasive in vivo optical probing of biological tissues is necessarily affected by 
both physical propagation effects and spectroscopy. These last two chapters have used 
well-defined in vitro model systems to validate the PVH algorithm. It is possible to show 
that across the exact range of chemical concentrations and density of physical scatterers 
encountered in biological systems of interest, the algorithm works well and with full 
internal consistency. It is always possible to find linear ranges for the EE and IE 
dependencies on the volume fractions because the dependence always approaches linear 
as the volume fraction of scattering centers approaches 0. Notwithstanding the usual 
complications in conduction experiments with RBC’s—that is, aggregation, oxygenation 
variation, and motion effects, even the blood mimicking experiments produced results 
essentially as expected.  
 The basic assumption of the PVH algorithm is that the system (of scatterers with 
concentration C) in question is optically “thin” or “dilute”. These terms relate to the 
exponentially decreasing dependence of the intensity of light as it penetrates a medium in 
the z-direction where there is absorption and scattering (for simplicity we will account for 
both with the variable µ). 
𝐼(𝑧) = 𝐼0𝑒
−µ𝑧𝐶   [6.3]  
Since the leading term in the general Taylor series expression (around z=0) for the 
exponential has the form for x=µzC:  
𝑒𝑥 = 1 + 𝑥 + 𝑥2 2!⁄ + ⋯   [6.4] 
Thus, for µzC being small enough e.g. if µzC<1 the higher order terms in Equation 6.4 
can be neglected and the dependence of the intensity decrease is always linear which 
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leads to two solutions. First, since z is the position variable, the properties of the system 
are contained in the product µC. If µC is large then the system is still linear if z is small 
enough, it is “optically thin”. If µC is small because C is small enough given the 
magnitude of µ, then the system is “optically dilute.” If given these parameters the optical 
distances involved (and produces adequately large spectroscopic signals) are the same or 
larger than the physical distances involved (e.g. in the dimensions of the cuvette), then it 
will not be possible to construct an in vitro model system without encountering wall 
effects in the data, as observed.  
 The most important part of the last statement is partially the wall artifacts 
observed in the in vitro system based on blood components are to be fully expected, and 
predominantly that in vivo systems have challenges for noninvasive chemical analysis 
using spectroscopy that are different. We have little recourse but to adopt to the nature of 
tissue as an analytical sample but “container effects” are much less of a problem when 
analysis of capillary blood in the outermost reaches of the epidermal-dermal boundary is 
the goal. Furthermore, when capillary blood is the goal the issue of RBC tumbling and 
other motion-induced scattering effects is obviated because the RBC’s execute 
constrained motion as they traverse such tight vessels, because there is no room to tumble 
and in fact they only traverse by deformation along the way.  
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7. Discussion, Future Work, and Conclusions 
 
7.1.   Discussion 
 Throughout my research we were confronted with the problem of trying to 
ascertain whether the PVH was actually measuring what we want and expect it to 
measure. Using the most direct path to this end, we showed that the algorithm produces 
unambiguous results when applied to in vitro systems. We coupled those results with 
independent results on in vivo systems for added credibility. However, these kinds of 
measurements have never been possible in in vivo systems before and so we immediately 
were confronted with trying to guess what the actual physiological results are. Thus to 
“harvest” that credibility we had to hypothesize what the actual physiological response is 
to the perturbations we employed. This also naturally led us to consider the clinical value 
of that information if we conclude that PVH actually measures the physical properties 
that we believe are being measured.  
Thus, the first hypothesis investigated was that the “Hematocrit acts as a ʻvital 
signʼ with only relatively small measurable changes over time due to physiological 
effects. The Hct monitoring can also be used to measure other vital signs such as the 
pulse rate and breathing rate for comparison.” The four commonly recognized vital signs 
are blood pressure, temperature, pulse rate, and respiratory rate. A vital sign is a 
measurable physiological parameter that is regulated by autonomic functions in the body 
and a change in one or more of the vital signs can indicate a medical problem. Efficient 
ways to measure these vital signs have existed for many years but we believe that if the 
Hematocrit was monitored with sufficient precision it could be added as a vital sign. 
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 The present standard method for measurement of Hct is to stick a finger (or do 
some other type of blood draw) to squeeze blood (and interstitial fluids) into a tube which 
is centrifuged in order to measure the height of the RBC column relative to the total 
height of the blood. The Hct value depends on the internal diameter of the vessels from 
which the blood is sampled. Alternatively the blood could be drawn from directly from a 
vein. Either way, the commonly accepted error and precision on this type of Hct 
measurement is about ± 2 units (due mostly to sampling errors) on a normal scale ranging 
from around 36 to 53. With this large of an error in the standard measurement, there 
would need to be even greater changes in the Hct for it to be used as a vital sign which is 
perhaps why it presently is not. Our measurement of the Hct takes an entirely different 
approach by analyzing the blood noninvasively by scattering from a laser which is 
recorded every 20 msec. Averaged over many hours of observation of motionless patients 
the variation from one measurement to the next is only ± 0.033 units which is 60 times 
better than the finger stick method.  
 Apparently, measurement of the Hct with the smallest physiological increment of 
± 0.033 units has allowed us to see small fluctuations that have never before been 
observed. One such observation is a standard medical procedure called the Valsalva 
maneuver in which a person tries to push air out of a closed orifice. The effect of the VM 
on other vital signs such as the blood pressure, pulse rate, and breathing rate has been 
measured previously so we can demonstrate that our measurement of the Hct, in Figure 
3.9, is consistent with the literature.29,30,57,58  
“Variations in the technique of the Valsalva manoeuver have been shown to 
greatly influence the pattern of cardiovascular response to the test”.82 For example, before 
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starting the Valsalva maneuver, the patient can either inhale or exhale producing different 
effects in the response. Inhalation before the VM causes the lungs to expand and take up 
more room in the thoracic cavity, causing a greater decrease in the venous return, which 
causes a greater decrease in the total ejected volume and therefore an increase in Hct. 
Exhalation before the VM makes for a less dramatic obstruction of the venous return 
allowing more plasma to slip through showing a decrease in Hct. The VM has been 
proposed83,84 as a noninvasive basis for cardiac health assessment precisely because many 
autonomic processes respond depending on the VM technique employed. What has been 
lacking is a sensitive, quantitative, continuous and noninvasive method for measuring 
relevant parameters in real time as they change during the VM.85 PVH would seem to 
offer an ideal and essential addition to the VM as a cardiac diagnostic.  
 Knowing that the increases and decreases in Hct make sense with a known 
physiological test, we can take a Fourier transform of the data to observe patterns in the 
Hct from both pulse rate and breathing rate. The pulse rate can be measured with an 
automated blood pressure cuff as shown in Figure 3.13 and corroborates with the Fourier 
transform data. Figure 3.13 describes an experiment where the legs end of a futon was 
raised while the patient was in the supine position. Orthostatic redistribution occurs when 
the orientation of the body e.g. the heart and circulatory system changes relative to 
gravity. The raising of the legs caused blood to rush to the head and showed a spike in the 
pulse rate from around 75 pulse/min up to around 80 pulse/min then the pulse rate 
relaxed back down to 74 pulse/min after equilibration to the new orientation. Taking the 
Fourier transform of the data to observe pulse rate was discovered after the data from 
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Figure 3.13 was published yet it only further gives evidence to the validity in the Hct 
measurement.  
 A Fourier transform of the data not only gives the pulse rate but it also gives the 
breathing rate. The oxygenation of the blood slightly changes the fluorescence of the 
RBC’s which is shown in the data. Demonstration of the breathing rate is given in Figure 
3.7 where 10 minute intervals of controlled breathing rates were observed. A normal 
breathing rate showed a strong peak at 0.26 Hz or 16 breaths/min. Changing the breathing 
rate to 10 seconds per breath gave a strong peak at 0.1 Hz and a breathing rate of 2 
seconds per breath gave a strong peak at 0.5 Hz.  
 From only one laser noninvasively probing the skin, we are able to monitor two of 
the commonly accepted vital signs, pulse rate and respiration rate, along with the 
Hematocrit/plasma volume which we believe could also be associated as a vital sign. We 
are able to measure the Hct to ±0.033 units from one measurement to the next and for a 
sedentary subject Hct generally stays within 1.0 unit over the course of a 2 hour 
experiment. Until now the changes in Hct from physiological stimuli that we observe 
would have been lost in the noise of standard measurements. A vital sign is only useful 
when the technology enables a measurement precise enough to determine changes on a 
scale relevant to physiological changes.  
We hold that this measurement of Hct would be useful as a vital sign if the 
instrument was in the hands of medical professionals. In addition to the Hct, the plasma 
volume seems to follow the blood pressure as well but more experiments are needed to 
make a quantitative connection between the two values. If the plasma volume could be 
used to measure the blood pressure and the Hct was taken as a vital sign, this device 
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could be used to measure all the vital signs continuously except temperature in real time 
through a simple noninvasive finger probe.  
The second hypothesis states that “changes in Hct due to loss of blood are 
measurable and significantly different from normal physiological changes.” Beyond use 
in noninvasive glucose monitoring by Raman spectroscopy, the purpose for developing 
the algorithm to measure the plasma volume and Hematocrit was to detect changes in the 
Hct from internal bleeding. To investigate blood loss in controlled situations, we were 
approved to conduct studies in a dialysis center and to do a study on rats. 
 Dialysis is necessary for cleaning the blood when a patient has renal failure. Many 
dialysis patients have an arteriovenous fistula inserted into their arm to provide a direct 
connection to a strong vein that can be repeatedly used for blood removal and 
replacement. During the procedure the patient is typically reclined in a chair for 3 to 5 
hours while the blood is cleaned. An FDA-approved device called the CRIT-LINE was 
developed to analyze the blood while it is in the dialysis machine in an effort to indicate 
if the dialysis machine is pulling or pushing either too hard or not hard enough. A 
machine set to pull or push against a human interface cannot determine if the pressure 
needs to be adjusted so the CRIT-LINE was designed to give patients a more comfortable 
dialysis procedure. The CRIT-LINE calculates a number that is not quite Hgb or Hct but 
reports both with the assumption that (Hgb=35*Hct) which is not necessarily constant 
over time or across patients. Nonetheless, this is an FDA-approved device that is safe and 
effective for that stated purpose. We were able to calibrate our algorithm by the CRIT-
LINE Hct output knowing that the Hct we measure in the finger is necessarily different 
but proportional to the Hct in a large vein. The difference is not entirely important 
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because the algorithm is designed such that we are only measuring changes from the 
prevailing Hct and plasma volume calculated at the beginning of an experiment.  
 The dialysis center was not only chosen for the comparison to the CRIT-LINE but 
also because there is a large portion of blood removed from a human patient in a 
controlled setting. Transfusion, infusion and blood donation centers such as blood banks 
are also ideal venues for testing. Finding patients with an internal bleed would be very 
difficult but the dialysis center offers a measurement on a human where the blood 
composition is being changed. After the blood has made its way through the dialysis 
machine cleaning impurities from the plasma, it flows back into the patient with the same 
RBC count but with fluids reduced. This gives an increase in Hct as the RBC’s stay 
essentially constant and the fluorescence of the plasma is decreasing. The motion defect 
in the probe from mismatched fiber optics makes some of the dialysis data difficult to 
follow but Figure 7.1 shows the observed Hct for three of the dialysis sessions with few 
motion defects.  
  
Figure 7.1. Hematocrit monitored for three different patients during a hemodialysis 
procedure.  
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 The first 5 to 10 minutes of data corresponds to an apparent increase in Hct due to 
bleaching of the static tissue yet the trend is continually increasing with the exception of 
the motion defects which are characterized by fast vertical jumps in the Hct. Figures 2.4 
through 2.6 highlight that the Hct measured by the LighTouch matches well with the 
FDA-approved CRIT-LINE while having the advantage of being truly noninvasive. 
Despite the motion defects (which will be easily fixed in the next model) as required the 
Hct can be seen to continue upward as the impurities in the blood are removed.  
 The observation of changing Hct with blood loss was also investigated in a rat 
model. Experiments in a rat model gives the advantage of controlled blood removal and 
addition while the rat is under anesthesia. The rat also has a much smaller supply of 
blood so the removal of only 2.5 mL corresponds to about 15% of the total blood supply. 
Differing from the dialysis experiments, the rat experiments can show the response of 
blood removal without reentry of blood back into the system at the same time. Figures 
4.4 through 4.6 show that when a large portion of the blood is removed the Hct 
consistently decreases. Figures 4.4 and 4.5 also show that when whole blood is added 
back to the system there is an increase in Hct compared to an addition of a blood 
replacement fluid where the Hct begins to increase at first but falls after the replacement 
fluid is added. 
 At the start of these experiments there were certain physiological effects that were 
not accounted for. The two that stand out are temperature and blood pressure. As the rat 
is anesthetized the blood pressure will drop which causes the rat to get cold. The rats 
were laid on a heating pad to keep them from getting too cold but the temperature was 
not measured in any of the experiments. Technology to measure the blood pressure in rats 
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has been known for many years86 but the Chaiken lab did not have the equipment to make 
this measurement. Changing blood pressure should show an effect on the PVH 
measurement and this technology would have helped elucidate if any of the changes in 
Hct were due to changing blood pressure. Figures 4.2 and 4.3 demonstrate the 
capacitance manometer that was used to measure changes in pressure under the paw. 
While this did give a pressure measurement that followed the trend in Hct, it was 
implemented towards the end of the study. If another rat study is planned, temperature 
and blood pressure would be measured in every experiment.   
 In both the dialysis experiments and rat model, the changing Hct is observable in 
real time. The dialysis creates a steady state with RBC’s moving out of and back into the 
body and the Hct increases with the removal of fluid borne impurities from the plasma. 
Experiments in the rat model show a decrease in Hct with removal of whole blood and an 
increase when whole blood is introduced back into the system. Both of these experiments 
give evidence to an observation of changing Hct over the background noise 
noninvasively in real time.  
 The third hypothesis states that “the PVH algorithm, used to calculate the 
Hematocrit in vivo, applied to a model system in vitro demonstrates the ability to 
accurately calculate changing concentrations of a two-phase optically thin system.” To 
model the blood, quartz spheres serve as a substitute for RBC’s and porphyrin as a 
substitute for plasma. Quartz spheres were chosen at a diameter analogous to the size of a 
red blood cell and the density of the solution was adjusted with CsCl in order to suspend 
the quartz spheres long enough for each measurement. For in vivo measurements the 
static tissue is assumed to be essentially constant and only the RBC’s and plasma change 
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giving two components measured by two signals, the EE and IE. This model system has a 
background signal from the CsCl solution and cuvette while having two changing 
components and the same two measured signals.  
 A training set was composed of six concentrations of each component in the 
linear range having all combinations of concentrations. Figure 5.3 demonstrates that both 
components display linearity in both EE and IE. A bilinear fit was applied for each 
component to model the change in signal for changing concentration to give the six 
constants in Equations 5.12 and 5.13 comprising the algorithm. The measured signals 
were then plugged back into the algorithm to determine how well it can predict 
concentrations within the linear range. Figure 5.4 demonstrates that the graphs of actual 
concentration vs. calculated concentration produce a fit with slope near 1 and intercept 
near 0 for each component.  
 To further investigate the ability of the algorithm to follow changes in 
concentrations, the mixed sample of quartz and porphyrin was analyzed over a longer 
time period. Our collaborator Jerry Goodisman had previously done modeling on 
sedimentation, similar to the quartz spheres settling, so he applied a similar model in 
Equation 5.17. The settling of the quartz spheres fit well with the sedimentation model 
and is shown in Figure 5.6. Trends in the EE were similar across multiple experiments 
where the signal would stay consistent for about 6 minutes then start to drop as the 
sedimentation front moved down past the focus of the laser. The IE however, did not 
show the same consistent trend across multiple experiments on the same sample. 
 It is known in the literature that porphyrin can photodegrade under near-IR 
irradiation. In the sedimentation curves, the IE signal has a constantly decreasing slope 
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superimposed on the same sedimentation curve from the EE. The second sedimentation 
of the same sample starts with the IE at the same intensity as it ended with after the first 
sedimentation while the EE has returned to the original intensity. This same type of 
experiment was repeated with a known quencher of the photodegredation, sodium azide, 
where the IE shows a similar shape to the EE over multiple sedimentation experiments in 
Figures 5.10 and 5.11. A secondary confirmation of the photodegredation was observed 
by the disappearance of the Soret absorption band upon irradiation in Figure 5.9. 
 Despite the sedimentation of the quartz and photodegredation of the porphyrin, 
the acquisition time was chosen such that the sample was essentially unchanged over the 
duration of observation for the training set. This two-phase optically thin system is well 
modeled by the algorithm to determine both porphyrin and quartz concentrations based 
on the measurement of both EE and IE. A good fit to a model system gives confidence 
that the algorithm is also behaving properly in the in vivo measurements.   
 The fourth hypothesis states that “physiologically relevant volume fractions of 
blood components show linearity with respect to both EE and IE.” In the volar side of a 
fingertip the profusion is about 3-5% with an Hct of about 0.1 giving a volume fraction of 
RBC’s between 0.003-0.005 and a plasma volume fraction of 0.027-0.045. The volume 
fraction of blood components was analyzed first at 785 nm excitation to parallel the 
experiments of the model system in Chapter 5. In determining the linear ranges the 
plasma was linear in both EE and IE well past the physiological range. The RBC’s, 
however, were only linear to around a volume fraction of 0.001 which is below the 
physiological range by a factor of three. But the capillary rich section of skin is only 
about 100-200 µm thick and the cuvette produces signals from 1-2 cm deep. Thus, the 
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cuvette/optical system creates a physically thick sample and container effect i.e. effects 
that would not occur in vivo are unavoidable in that particular in vitro venue. 
Nonetheless, the blood components could still be analyzed within the linear ranges to 
verify the fit of the algorithm.  
 A training set was devised with six volume fractions of RBC’s and six volume 
fractions of plasma analyzing every combination. The measurements were relatively 
linear and fitting to the algorithm gave slopes near 1 and intercepts at 0 within 
experimental error. Within the linear ranges the algorithm works well with the blood 
components but the RBC’s deviate from linearity at the normal physiological range. At 
785 nm excitation the scattering, absorption and fluorescence of RBC’s is greater than at 
longer wavelengths which is why in vivo measurements are made at 830 nm. If the 
scattering from RBC’s is sufficiently decreased at 830 nm then the physiological range of 
volume fractions should fall within the linear range.    
 Having demonstrated that the components of blood can be modeled by the 
algorithm within linear ranges at 785 nm excitation, the instrument used to analyze blood 
in vivo at 830 nm excitation was adapted for in vitro experiments. Measurements in vivo 
are made with a finger probe attached by fiber optics which can be detached in favor of a 
liquid probe. The liquid probe was mounted analogous to the 785 nm system where the 
laser enters the cuvette from the top and collects the backscattered light.  
 At 830 nm excitation the RBC’s showed linear behavior in the EE to more than 
double the volume fraction of the physiological range. However, the IE only showed 
linear behavior to 0.005 volume fraction which is right at the top of the linear range. The 
images in Figure 6.1 demonstrate what happens to the scattering when the volume 
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fraction of the RBC’s is large. As the volume fraction of RBC’s increases, the depth to 
which the laser penetrates decreases and extraneous scattering starts at the bottom of the 
cuvette but eventually moves outward towards the walls of the cuvette. To investigate the 
effects of the RBC’s scattering on the light reaching the focus, a 90 degree nephelometric 
geometry was designed. 
 The LighTouch device employs different fiber optics for the laser and the detector 
allowing two different probes, one with the laser and the other with the detector. Both of 
the probes were mounted such that the laser probe was in the z-axis and the detector 
probe was in the x-axis with the foci of both probes were overlapped in space. If the 
volume fraction of RBC’s was scattering the majority of the light before reaching the 
focus, this geometry should show a large decrease in signal reaching the detector. Data in 
Figure 6.7 does show that increasing the volume fraction of both RBC’s and plasma 
within the physiological range decreases the signal reaching the detector.  
 Volume fraction of both RBC’s and plasma within the normal physiological range 
at 830 nm excitation show linearity in the EE signal. When analyzed separately the IE 
was well behaved enough for linear results, however, the mixing of both RBC’s and 
plasma at the physiological range resulted in less than linear trends. A secondary 90 
degree geometry demonstrates that the turbidity of the samples is hindering light from 
reaching the focus and likely causing multiply scattered photons to reach the detector. 
 Analyzing the components of blood in a cuvette serves to model the in vivo 
measurements yet it is not exactly the same. When the laser probes the skin in vivo, there 
is a layer of static tissue (about 100 µm) with a much lower scattering coefficient before 
the laser makes it to the capillaries. In vivo systems are physically thin in addition to 
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being optically thin and this makes designing a simple in vitro system to mimic in vivo 
systems difficult with currently available instrumentation. The laser then reaches the 
capillaries, which have about a 10 µm diameter containing the blood with the larger 
scattering coefficient. In comparison, the in vitro blood experiments have the highly 
scattering RBC’s mixed throughout the entire solution causing the scattering to be spread 
over the entire depth of penetration (≈1 cm). Even with this difference against the in vitro 
experiment, there is still linearity within the physiological range of both RBC’s and 
plasma. The algorithm only works within the linear range and by sheer luck (for in vivo 
systems that are simultaneously physically and optically thin) the physiological range of 
RBC’s and plasma give linear results for both EE and IE.  
 
7.2.   Future Work 
 The work presented here is part of an ongoing project in noninvasive in vivo 
blood analysis that is far from finished. The project started with a noninvasive measure of 
blood glucose and transitioned into a measure of plasma volume and Hematocrit before I 
joined the lab. Measurement of PV and Hct is important in the detection of internal 
bleeding which is the leading preventable cause of death worldwide, military or civilian, 
for all people ages 18 to 47. There is still work to be done to make PVH ready for market 
to be used in medical settings. Alternatively, a turbidity corrected measure of plasma 
volume from PVH gives the ability to associate Raman intensity from blood glucose (or 
other potential analytes) to a volume for a noninvasive blood glucose concentration in 
vivo. 
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 One of the greatest obstacles in the PVH research right now is the motion defect 
from a mismatch in fiber optics. Fixing the motion defect is simple but it would require 
that the instrument be recalibrated for the algorithm. The immediate downside in needing 
to recalibrate is that new results may not be correlated to the data as it is presently 
calibrated. It is probable that previous experiments may need to be repeated on the new 
calibration. An immediate benefit to fixing the motion defect is that it could open new 
avenues of research such as active physiology. The instrument is being used as it is now 
and is producing new and interesting results but the fear is that trying to fix the motion 
defect could cause new unforeseen problems that hinder the research. With knowledge 
that the probe will eventually be fixed, the future work will include experiments with a 
device that does not have the motion defect.  
 As mentioned above, the PVH algorithm could be used for interesting studies in 
the area of active physiology. With enabling technologies advancing in recent years, it is 
conceivable to imagine a new design that could fit the hardware of the device in the size 
of a watch and transmit the data wirelessly. This type of design could be used to give 
valuable information to athletes; for example, a marathon runner could have an indication 
from the plasma volume that dehydration is setting in. In the long term baseline 
experiments the Hct tends to drift up and the plasma volume tends to drift down. Part of 
this effect is due to insensible water loss from both respiration and perspiration. One 
could imagine that the plasma volume could be used to track when there has been a 
significant loss of fluid to indicate a need for rehydration.  
 Due to the motion defect, and the absolute necessity of establishing normal 
baseline behavior, experiments so far have been limited to minimal movement. It would 
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be interesting to monitor people exercising in different manners to observe how the blood 
flow and composition are affected. Does an exercise like rowing, where the person is 
sitting, have a different effect on the blood flow than running where the person is 
standing? Are there observable differences in blood flow from lifting weights compared 
to cardio-oriented exercises? Breathing rate and pulse rate from a wearable would also 
give additional information for these types of studies. There are so many possibilities of 
interesting questions that could be answered if this technology was utilized in active 
physiology applications.  
Aside from the fluid loss from perspiration and respiration, there is also a change 
from the kidneys removing fluids which produces an increase in Hct and a decrease in 
plasma volume. Figure 7.2 shows one baseline experiment where kidney function appears 
to turn on at around 600 Hemocycles. This type of response in the signal could be useful 
for medical professionals who care for patients who either have difficulties with 
communication or lack the capacity to indicate a need to use the restroom. From the 
baseline experiments that we have done, we believe that it may be possible to observe the 
kidneys turning on before the patient even notices.  
127 
 
 
 
Figure 7.2. Measured PV and Hct in a resting patient where the bladder appears to turn 
on at around 600 hemocycles. 
 To study the effects of the kidney activity on Hct and plasma volume in a 
controlled study, we could use a diuretic called Lasix87, which turns on the kidneys, and 
an antidiuretic Desmopressin88,89 as a negative control which reduces urine production. 
Both of these are prescription drugs and are not difficult to obtain for experiments. Lasix 
is known as a “loop diuretic” which shows a high (<95%) binding affinity to proteins 
such as human serum albumin, which could potentially show changes in the Raman 
signal. Figure 2.2 shows a typical spectrum of a human finger which has Raman features 
above the fluorescence baseline mainly due to protein. If the Lasix were to make a large 
enough effect on the protein content, it could show a change in the Raman spectrum. 
Even if the Raman spectrum does not change significantly, there should be measurable 
differences in the Hct and plasma volume corresponding to the increased kidney function. 
Desmopressin works as an antidiuretic to reduce the amount of water that is eliminated 
by the urine. There should still be changes in the Hct and plasma volume but it should 
show opposite effects from the Lasix. Lasix should show an increase in Hct until the 
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bladder needs to be evacuated and the Desmopressin should show an increase in plasma 
volume with a corresponding decrease in Hct. 
 A condition called Raynaud’s disease90, which can cause loss of blood in the 
fingers due to cold or emotional stimuli, would make for an interesting study. In the early 
2000’s when the Chaiken lab was working on glucose, they would apply pressure to a 
finger to evacuate the blood for a “blank” sample. Raynaud’s disease causes 
vasoconstriction in the fingertips which evacuates RBC’s making the fingers look devoid 
of color. Analyzing patients with Raynaud’s disease before and after the vasoconstriction 
could give a quantitative measurement of how much of the in vivo signal comes from the 
RBC’s. With good technique, applying pressure evacuates a significant amount of the 
blood from the probed region but a patient with Raynaud’s evacuates much more of the 
RBC’s from the region. 
 In a different direction, temperature effects could be observed in the blood. The 
blood is largely used for temperature regulation so in response to cold the body has 
autonomic compensation mechanisms. When exposed to the cold, the body will give 
preference to keeping the core warm and uses a mechanism called cold-induced 
vasodilation (CIVD) to periodically send more blood to the extremities. In studying the 
effects of gloves and wind on cold fingers, Shitzer et. al.91 measured the temperature of 
the finger exposed to cold. At about 20 minute intervals there was an increase in 
temperature that they assume is due to changes in the blood flow. This is something that 
we could actually measure in real time1 and we could do it with the instrument as it is 
now.  
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The easiest way to measure this may be to move the instrument to a walk-in 
freezer without gloves on to measure the plasma volume and Hct over time. To give a 
secondary measurement, a temperature probe could be connected to an adjacent finger at 
the same spot as the probe to measure changes in temperature along with the PVH. We 
should be able to reproduce the results from Shitzer et. al. along with providing more 
information about the blood flow and composition. A downside to the walk-in freezer is 
that it could cause problems with the cooling function of the instrument (since the freezer 
is colder than the detector) or changes to adhesives within the instrument. A similar effect 
could be obtained by blowing air over dry ice onto the hand with the probe.  
 Finally, an improvement to the experiments in Chapter 7 could come from using 
tissue phantoms92 to more accurately model the different volume fractions of blood 
components in the capillaries. The in vitro model in a cuvette served the purpose to 
demonstrate that the physiological ranges of plasma and RBC’s show linearity when 
dispersed in the entire volume. Using physically thin tissue phantoms that avoid 
edge/finite size effects would give a better model having the RBC’s and plasma 
contained in a small diameter just below the surface. Designing the phantom limb to 
anatomical proportions for a finger may not be difficult93 but including something like 
capillaries below the surface could potentially be challenging. Along with the difficulties 
of adding something like capillaries, there could be melting issues with blood absorbing 
the excitation. 
 To summarize the ideas from this section, with a technology making a 
physiological measurement that was previously unobtainable, there are numerous areas to 
study that could reveal subtle changes in blood dynamics. A huge area for potential 
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research lies in active physiology including all kinds of exertion of the body. It would 
also appear that PVH could be used to detect when the kidney function begins to fill the 
bladder so a study with diuretics and antidiuretics could help show the usefulness for a 
medical professional to noninvasively monitor the kidney activity in, for example, an 
unconscious patient. Patients with Raynaud’s disease could be utilized to study the 
effects that an absence of RBC’s in vivo would have on the algorithm. A cold stimulus 
could be used to observe an autonomic cold induced vasodilation response as the body 
tries to warm a cold limb. Lastly, the use of tissue phantoms could improve upon the in 
vivo blood analysis by providing a sample that is both physically and optically thin as is 
the tissue in a finger above the capillaries.   
 Measurement of the plasma volume and Hct has the potential to provide important 
information to clinicians but the future plan is to move towards a better measurement of 
glucose. With the improvement of enabling technologies since the early 2000’s and now 
a turbidity corrected measurement of plasma volume by PVH, the noninvasive in vivo 
measurement of glucose might be possible at a sufficient precision. The production of a 
small noninvasive device providing an accurate measurement of blood glucose in real 
time could revolutionize the management of diabetes for those who cannot stand 
constantly pricking their fingers.   
 
7.3.   Conclusions 
 This work describes the ongoing analysis of blood noninvasively in vivo along 
with the in vitro validation of the algorithm. The blood is taken as two components, red 
blood cells and plasma, both of which cause elastic emission (from Mie and Rayleigh 
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scattering) and inelastic emission (from fluorescence and Raman emission) in varying 
quantities from a single light source at 830 nm. Having two components and two 
measured quantities, two independent linear equations can be used to correlate each 
component to the measured EE and IE. Red blood cell volume and plasma volume are 
given by the equations which are then used to calculate the Hematocrit (volume fraction 
of RBC in the total volume of blood). From this approach, the Hct can be measured to a 
smallest physiological increment of ± 0.033 units compared to ± 2.0 units from the 
standard blood draw method. With this new level of precision, subtle changes can now be 
observed which were impossible before. We hold that with this new level of precision, 
the Hct could potentially be used as a new vital sign. 
 The first question to ask when measuring something new is if it actually works. 
The measurement of Hct itself is not new but this level of precision with a continuous 
noninvasive measurement certainly is new. Enough is known about the circulatory 
system to meaningfully compare match our results with the common understanding of the 
physiology involved. We have observed changes in the plasma volume and Hct from 
fluid shifts on a tilt table, the Valsalva maneuver, dialysis patients, and whole blood 
removal from a rat model. Each of the various measurements appear to behave as would 
be expected from the known physiology further giving evidence that we are in fact 
measuring changes in the plasma volume and Hematocrit in real time. Further evidence is 
given by in vitro demonstration of the algorithm on both a model system and blood. As 
long as the sample is optically thin and the collected photons are singly scattered, the 
algorithm behaves as expected and gives good results.  
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 The second question to ask is if it would be useful outside of the research lab. We 
have shown that an important application for the measurement of PVH is for real-time 
noninvasive detection of internal hemorrhaging. More testing is needed but it would 
appear from the rat experiments that changes in response from blood loss are greater than 
the baseline changes. Presently there is not a commercially available device which can 
noninvasively monitor the blood to determine if there is an internal bleed.  
From the trends in the Hct we have also shown that two vital signs, respiration 
rate and pulse rate, are observed by a Fourier transform of time domain PVH 
measurements. It may be possible for a medical professional to monitor if a patient is 
sleeping or awake based on changes in the respiration rate and pulse rate. It would also 
appear that changes in the Hct slope could give an indication of when the bladder is 
filling. The combination of these vital signs in a compact device could serve to improve 
the quality of care in a medical setting by providing new information for the medical 
professionals.  
The final question is where the future of this research lies. It would certainly seem 
that this PVH technology is moving towards becoming a commercially viable product to 
be found in many diverse medical settings. As it is now, this device could report plasma 
volume, Hct, respiration rate and pulse rate without needing the capability to measure a 
Raman spectrum, which would decrease the size and cost of such a device. It would also 
seem that with the plasma volume from PVH and improved enabling technologies the 
time to start working towards a noninvasive in vivo measure of blood glucose is near. The 
ability to measure a glucose signal from the Raman scattering noninvasively in vivo while 
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correlating it to a quantitative, turbidity corrected measure of volume should give a 
reliable measure of the blood glucose to become the new FDA standard of care.           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix A: IRB in vivo Human Study Protocol  
 
 
TITLE OF STUDY: IN VIVO RAMAN SPECTROSCOPY (IVRS) OF HUMAN 
FINGERTIP CAPILLARY BEDS:  
A PILOT STUDY 
 
Research Protocol: 1 June, 2012 
 
Background: 
The leading preventable cause of death for people between 18 and 45 world-wide is 
uncontrolled internal bleeding i.e. hemorrhage (A. Sauaia et al, J. Trauma 38, 185–193 
(1995)). Internal bleeding can be very difficult to reliably detect when there is no visible 
external injury and the rate of blood loss is not rapid. Two indicators of rapid blood loss 
are fluctuations in hematocrit and blood protein concentration.  Monitoring of either of 
these analytes requires an invasive blood draw and at least 3-5 minutes to obtain a single 
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measurement. The LighTouch™ device shines imperceptible red light onto the skin and 
measures the light that reflects back using the method of Raman Spectroscopy. Some of 
this light is color shifted and some is not. Using a validated, proprietary algorithm (J. 
Chaiken et al, J Biomed Opt 14(5), 050505 (2009) & 15(3), 037007 (2010)), the 
LighTouch™ device combines the signal in this remitted light and calculates hematocrit, 
glucose, protein and potentially other analytes. The resultant information is derived 
without painful physical insult to the patient and can trend changes in these blood 
analytes in order to predict the need for intervention.  
Previous IRB approved clinical trials over the last 10 years at SUNY Upstate Medical 
University using this method demonstrated useful performance for blood glucose. We 
propose to validate the same procedure here for hematocrit and protein. Since hematocrit 
and protein concentrations change during hemodialysis, that setting provides an ideal 
model to monitor these fluctuations over time and assess the precision and accuracy of 
the LighTouch™ device. This technique will not affect the usual dialysis treatment in any 
way. The subject will place one finger into the machine for exposure to a harmless 
incoming light signal.  Sensors within the machine will detect light scatter allowing 
calculation of analytes and parameters such as total protein and hematocrit. Literally 
hundreds of individuals have experienced the LighTouch™ device since 1999 (beginning 
with SUNY HSC IRB #3920 (4/3/99) and since Crouse Hospital IRB Approved Protocol 
2007.1629 (8/23/07) with several subsequent renewals) and there has never been an 
unpleasant response or adverse outcome. The system is analogous to having a laser 
pointer shining on one's finger-tip. The ultimate goal of this research is to develop the 
device into a reliable non-invasive measure of critical blood analytes that can be 
determined quickly and accurately at the patient's bedside.      
 
Specific Objectives 
To ascertain if spectroscopic signals obtained from IVRS technology and methodology 
can be associated with hematocrit variations, plasma/red blood cell volume fluctuations, 
and potentially other blood analytes (whole blood protein) changes.  
 
 
Eligibility Criteria: 
Study subjects will be recruited from patients who receive routine hemodialysis at the 
University Dialysis Center.  Prospective subjects who will be eligible include: 
1. Adults age 18 and above; 
2. Able and competent to fully understand and provide informed consent; 
3. Stable on routine dialysis treatment for at least 3 months with no clinical evidence 
of on-going bleeding. 
Children and pregnant women are excluded from this Pilot study. The exclusion of 
children is due to the mechanical limitation of the LighTouch™ device probe, which is 
designed based on adult ergonomics and anthropometrics. The exclusion of pregnant 
135 
 
 
women is due to the unclear influence of laser exposure to both the mother and fetus at 
this point in time. Both populations will be studied in the future. 
 
Study Design: 
In parallel with the standard hemodialysis procedure, test subjects will use the 
LighTouch™ device to provide spectra of their blood in vivo during times of relatively 
rapid change in blood volume, ie at the onset and conclusion of dialysis. We will first 
collect several minutes of baseline IVRS spectra for each subject and then monitor the 
spectral variations for 30 min after initiation of the hemodialysis treatment. Since a 
typical hemodialysis procedure takes approximately 3.5 to 4 hours, subjects will have the 
option to suspend the IVRS measurements during the majority of the treatment session 
for convenience. Light scatter readings using the finger probe will resume for the final 30 
minutes of the hemodialysis procedure. We anticipate that hematocrit, plasma/red blood 
cells volume, and protein analytes are changing most rapidly at the beginning and the end 
of a hemodialysis cycle when approximately 250 cc of priming volume is infused and 
removed respectively affording the opportunity to monitor this variation. 
Results will be compared with (1) the same signals observed over repeated measures 
during the baseline collection period; (2) an existing FDA approved commercial blood 
flow monitor CritLine (Hema Metrics, Kaysville, Utah); (3) hematocrit and total protein 
obtained through routine lab examinations within the standard of care. This strategy will 
be deemed valid if hematocrit and protein variations calculated from related 
spectroscopic signals are consistent with existing technology (#2) and gold standard lab 
evaluations (#3). 
 
Statistical Methods, Data Analysis and Interpretation: 
The LighTouch™ device has been shown to provide reliable and reproducible spectra of 
blood and tissues in human fingertips (J. Chaiken et al, Review of Scientific Instruments 
81, 034301 (2010)). Therefore, a relatively small sample size of 10 – 20 test subjects will 
be recruited in the pilot study. For statistical purposes, at least 3 – 5 subjects with 
different dialysis access, e.g. arteriovenous fistula, temporary dialysis catheters, gortex 
grafts, etc., will be included. Because of the continuous readings obtained with IVRS, 
thousands of data points will be obtained with each subject. 
Results will be interpreted as a comparison between expected hematocrit/plasma/red 
blood cells volumes variation patterns based on existing CritLine and lab values when 
compared with IVRS data. 
 
Confidentiality: 
All subject specific information will be de-identified during data acquisition by assigning 
a random number to each subjects data-collection tool. Strict adherence to HIPPA 
regulations will be followed. Data will be encrypted on a password protected laptop 
which will be housed in a locked location and accessible only to study personnel. 
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Study Flow Chart: 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Take the blood pressure and pulse rate of 
the patients and engage their fingertips 
with the LighTouch™ apparatus 
 
Preparation and set ups for 
the routine hemodialysis 
procedure and CRIT-
LINE monitor 
 
Expose the fingertip with laser for 
100 sec and then start collecting 
baseline spectra 
 
Start hemodialysis 
 
Start IVRS measurements 
 
Stop hemodialysis 
 
Stop IVRS measurements 
 
Data processing, analysis, 
interpretation, and comparison with 
references 
 
Organize notes and CRIT-LINE 
readings taken while performing 
hemodialysis procedure 
 
Refusal 
Agree to participate 
Review potential subjects 
for inclusion criteria 
 
PI and co-investigators explain benefits/risks and 
protocol to potential subjects and seek informed 
consent 
 
Introduce the LighTouch™ device to subject 
before onset of routine dialysis session and 
familiarize with finger sensor 
 Stop 
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Anticipated Outcomes & Risks: 
The LighTouch™ device was used in four prior Upstate and SU IRB approved studies 
between March 1999 and March 2011. Several hundred of subjects were studied with the 
device and there were no incidents of sensation or major or minor long-term effects. The 
device uses near infrared light very similar to a CD player laser. Near infrared light is low 
energy, non-ionizing light very similar to light from a heat lamp. Although it exceeds the 
FDA exposure limit, we propose to use <200 mW/cm2 since recently, Feld and co-
workers at MIT/ Deaconess (J. Biomed. Opt. 10, 031114 (2005))  report results from an 
IRB approved study that used 300 mW (i.e. 0.3 Watts) while reporting minimal 
discomfort to only one of 24 volunteers and no histological damage to anyone as checked 
microscopically by a dermatologist. Our previous COPD related protocol at Crouse 
Hospital was allowed for 200 mW with no adverse effects observed. 
The IVRS is a noninvasive technology and the nature of this study is observatory with no 
intervention to the normal dialysis procedure. Therefore no risks or long term medical 
consequences are anticipated. The results of this study are expected to refine the 
capability of the LighTouch™ device in continuous noninvasive in vivo blood 
hematocrit, plasma/red blood cells volumes, and other blood bearing analytes monitoring. 
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